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Abstract
ARPITA GHOSH: Conditional Likelihood for Risk Estimation in Genome
Scans and Coefficient Shrinkage.
(Under the direction of Dr. Fred A. Wright and Dr. Fei Zou)
It is widely recognized that genome-wide association studies suffer from inflation of
the risk estimates (commonly known as the “winner’s curse” or “significance bias”) for
genetic variants, usually single nucleotide polymorphisms (SNP)s, identified as signif-
icant in the genome scan. To handle such significance bias, a number of investigators
have proposed using likelihoods that condition on the declared significance of the out-
come. We describe an approximate conditional likelihood approach that can be applied
using estimates of odds ratios and their standard errors provided by standard statis-
tical software. We also discuss extensions to the situation where, to supplement the
primary analysis, risk estimation is performed for multiple correlated phenotypes or
gene-environment interactions in the genome scan. The results have considerable im-
portance for the proper design of follow-up studies and risk characterization. Our con-
ditional likelihood approach also lends itself naturally to regression settings, in which
shrinkage of multiple coefficients is performed. We use our conditional likelihood to
propose a new regression penalty function, and demonstrate that it is competitive with
other penalized regression procedures in both low-dimensional and high-dimensional
settings.
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Chapter 1
Introduction
Over the past few years a large number of genotype-phenotype associations have been
reported in the genome-wide association study (GWAS) literature. However, many of
these reported associations have not been replicated (Hirschhorn et al. 2002; Lohmueller
et al. 2003). Among those associations that have been replicated, the estimated genetic
effect size in the replication sample has often been smaller than that observed in the
original GWAS (Todd et al. 2007; Yu et al. 2007; Levy et al. 2009). We investigate one
of the possible reasons behind these phenomena, namely that estimates of effect sizes
are upwardly-biased simply due to the fact that the genetic variants were selected for
having achieved statistical significance.
In a GWAS the objective is to identify genetic variants (SNPs) conferring disease
susceptibility. Once such a variant is detected, interest lies in quantifying the genetic
effect of that variant on the phenotype, based on the same data. For modern whole
genome scans, 100,000 to 1 million SNPs may be genotyped. To control family-wise er-
ror or false discovery rates, point-wise significance thresholds must be very conservative
(Zondervan and Cardon 2007; Todd et al. 2007; Scott et al. 2007), typically in the range
10−7−10−8. Using the same dataset for testing and estimation purposes, together with
the application of stringent thresholds, distorts the estimation process and produces
inflated estimates of effect sizes for significant SNPs. This phenomenon is commonly
known as the “winner’s curse” (Lohmueller et al. 2003; Zo¨llner and Pritchard 2007) or
“significance bias” (Ghosh et al. 2008). For example, in a GWAS of blood pressure
and hypertension for the CHARGE Consortium reported by Levy et al. (2009), effect
size estimates were reported for all thirty SNPS representing the ten most significant
loci for each of the three phenotypes systolic blood pressure, diastolic blood pressure,
and hypertension. Each of these estimates was higher in magnitude than the estimates
in a replication study reported by the Global BPgen Consortium, representing strong
empirical evidence for the significance bias phenomenon.
One implication of significance bias is that if the biased estimates are used for the
design of replication studies, these replication studies are likely to be underpowered.
In addition, the true standard errors of risk estimates can be greatly inflated by the
selection procedure. Also, standard confidence intervals for risk estimates can have
very poor coverage properties. Although significance bias has been investigated and
documented in detail, very few methods have been proposed for reducing or eliminating
it.
We have developed a conditional likelihood approach to reduce this bias, which ap-
plies in a variety of testing settings (Ghosh et al. 2008). Among the most attractive
settings is the analysis of case-control association studies, for which the number of tests
(SNPs) is very large, and for which the genetic risk effects are important, interpretable
quantities. Our approach is based on the estimate of the genetic effect and its standard
error as reported by standard statistical software. Thus it does not require access to
the original data and can be applied to published studies, and our method is far easier
to implement than competing approaches. We also provide a principled method to con-
struct confidence intervals for the genetic effect while acknowledging the conditioning
on statistical significance. We have evaluated the performance of the proposed method
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via extensive simulations for a range of genetic models, minor allele frequencies and
genetic effect sizes. Finally, we have applied it to published datasets to demonstrate
the relevance of our approach to modern whole genome scans.
As an extension to the problem of reducing significance bias for disease risk effect, we
have considered the situation where selection of a significant SNP is performed on the
basis of one trait, but we wish to perform inference on the risk effect of the significant
SNP for another trait (e.g. Type II diabetes and obesity). An immediate problem arises
in performing valid inference for the secondary phenotype for a (retrospective) case-
control design. If the secondary phenotype is associated with the disease status that
forms the basis for case-control comparison, then standard logistic or linear regression
applied to the secondary trait can produce severely biased estimates of the secondary
risk effects (Nagelkerke et al. 1995; Jiang et al. 2006; Lin and Zeng 2008).
While the secondary analysis for case-control association studies has been addressed
by many researchers in the GWAS literature (Jiang et al. 2006; Scott and Wild 2002;
Richardson et al. 2007; Scott and Wild 1991; Lee et al. 1997; Lin and Zeng 2008),
we describe a novel retrospective likelihood method to analyze binary or continuous
secondary phenotypes. The approach models the joint distribution of the disease and
secondary phenotypes such that the marginals for each phenotype respect the conven-
tional models. Specifically, we specify the joint distribution such that the marginal
distribution for the disease phenotype is logistic and that for the secondary phenotype
is logistic or linear for binary or continuous secondary phenotypes, respectively. The
approach has considerable appeal as an alternative analysis procedure for secondary
phenotypes.
Using our approach for secondary analysis, we next describe a general approach
to bias-correction that includes correction for a variety of secondary effects, including
risk effects for secondary phenotypes, as well as the estimation of gene-environment
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interaction effects. Here bias correction is necessary if the the SNPs of interest have
undergone initial significance selection for the primary phenotype, and it is of interest
to perform inference for the secondary effects. We demonstrate that the significance
bias problem can be substantial for the secondary effects, and is closely related to the
correlation between the primary and secondary effect estimates. The problem of signif-
icance bias in the estimation of secondary effects has received relatively little attention
in the GWAS literature. To address this problem, we have developed an extension of
our conditional likelihood approach to a multivariate setting, where multiple effect co-
efficients are estimated simultaneously . For implementation of this method we require
the estimates of the effect sizes, their standard errors, and an estimate of the covariance
between them. For secondary phenotypes, we provide formulas to estimate the relevant
covariances, and the method can be implemented very easily. We have also developed
the method to handle the situation where gene effects, as well as environmental effects
and gene-environment interactions are all estimated simultaneously. In addition, we
have shown analytically that if we first fit a reduced model for disease risk on gene
only, and follow up with a full model only if the reduced model is declared significant,
then the effect size estimate for the gene-environment interaction obtained from the
full model is not asymptotically biased.
Finally, it is worth noting that the bias-correction procedure is intended to reduce
the mean-squared error of effect estimates, with significance thresholds that are es-
pecially useful when the proportion of true alternatives is low. Moreover, the effect
estimates that are not significant may be thought of as having been thresholded to
zero. In this manner, our conditional likelihood approach may be compared to the
shrinkage of coefficient estimates and thresholding that is applied in existing penalized
regression procedures. We demonstrate that our conditional likelihood can be used
to formulate a new penalty that can be used in a regression framework in situations
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where the sample size is larger than the number of predictors. By implementing a
significance threshold as a tuning parameter for individual predictors, the procedure
can create a sparse set of predictors with non-zero coefficient estimates. In addition, we
describe a conditional regression procedure that can be used to obtain estimates for our
method when the number of predictors is larger than the sample size. When combined
with cross-validation, our procedure is an automatic variable selection and coefficient
shrinkage approach that is a competitive approach for prediction in high-dimensional
regression settings. We demonstrate via simulation that the procedure has good pre-
diction error properties in comparison to competing approaches, especially when the
proportion of nonzero coefficients is small.
5
Chapter 2
Estimating Odds Ratios for Disease
Risk in Genome Scans
2.1 Introduction
In genetic studies, it is widely recognized that the control of genome-wide error requires
the use of stringent thresholds for significance testing. For genome-wide linkage scans,
standard LOD significance thresholds in the range 3.0 to 4.0 correspond to point-wise
p-values in the range 10−4–10−5, depending on the model and study design (Lander
and Kruglyak 1995). For modern genome-wide association studies (GWAS), 100,000
to 1 million SNP markers may be genotyped, and control of family-wise error or false
discovery rates typically requires point-wise significance thresholds in the range 10−7–
10−8 (Zondervan and Cardon 2007; Todd et al. 2007; Scott et al. 2007). The use of
such stringent thresholds is offset somewhat by the belief that GWAS offer greater
power than linkage studies for detecting complex disease genes (Risch and Merikan-
gas 1996). Nonetheless, the application of stringent thresholds distorts the inferential
process, producing estimates of disease risk effect sizes that may be, on average, far
greater in magnitude than the true effect (Lander and Kruglyak 1995; Zondervan and
Cardon 2007; Allison et al. 2002; Chanock et al. 2007; Garner 2007; Go¨ring et al. 2001;
Hirschhorn et al. 2002; Ioannidis et al. 2001; Lohmueller et al. 2003; Siegmund 2002; Sun
and Bull 2005; Yu et al. 2007; Zo¨llner and Pritchard 2007). This phenomenon has been
described as a form of “winner’s curse” by Zo¨llner and Pritchard (2007) and others, or
as a form of regression to the mean (Yu et al. 2007), and has profound importance for
genome scans. Although the problem has been described as primarily an issue of bias,
we demonstrate below that the variance of risk estimates can also be greatly inflated
by the selection procedure. Moreover, standard confidence intervals for risk estimates
will have very poor coverage properties, although this issue seems to have received less
attention.
Consider a genome association scan for a complex disease in which 10 genomic
regions contain disease genes, and each region has a 20% chance of meeting genome-
wide significance. Assuming independence of regions, the genome scan has respectable
power 1 − (1 − 0.2)10 = 0.89 to achieve significance in at least one region. However,
a repeated genome scan of equal size will have power of only 0.2 for any one region,
and thus likely not result in “replication” of the first study. A follow-up study might
focus on a single significant region, using fewer markers and paying a lower penalty
for multiple comparisons. But if the results of the initial genome scan are used as a
guide, the follow-up study is likely to be underpowered, relying on an inflated estimate
of locus disease risk.
As a statistical phenomenon, the winner’s curse should not be confused with addi-
tional sources of bias, including variations due to genotyping technologies, or hetero-
geneity of patient populations from which samples are drawn (Lohmueller et al. 2003;
Balding 2006; Wang et al. 2005). The winner’s curse is investigated in detailed simula-
tions elsewhere (Garner 2007; Go¨ring et al. 2001; Siegmund 2002; Sun and Bull 2005;
Yu et al. 2007; Zo¨llner and Pritchard 2007), including a recent paper by Garner (2007),
7
who clarified that the bias can be understood largely through the behavior of Wald
statistics for log odds ratios.
Although the bias is simple to understand and to document, reducing or eliminat-
ing it may be nontrivial. Zo¨llner and Pritchard (2007), have described a likelihood
approach which requires maximization over numerous parameters, including genotype
frequencies and penetrance parameters, while conditioning on declared statistical sig-
nificance. Their procedure reduces the bias in risk estimation, but cannot be performed
using standard statistical software. Yu et al. (2007) have recently applied bootstrapping
to correct for significance bias Both of these bias correction approaches are technically
feasible for genome scans, but would be highly computationally intensive in that setting.
We describe our alternative approach for estimating genetic effects in terms of odds
ratios, which have numerous advantages that have made them standard for analysis
of case-control designs (Aschengrau and Seage 2003). A crucial advantage for case-
control studies is that the odds ratio (OR) may be estimated consistently, whether the
study design is prospective or retrospective (McCullagh and Nelder 1989), and the OR
has an interpretation distinct from nuisance parameters such as genotype frequencies.
Moreover, in logistic models the OR retains interpretability in the presence of covariates,
which is increasingly important for complex disease investigations.
In this paper we introduce a method to correct for significance bias in disease asso-
ciation studies, using an approximate conditional likelihood. The approach is directly
based on the OR estimate and its standard error as reported by standard statistical
software, and applies to dominant, recessive, or additive genetic models. No modifica-
tion is necessary when covariates such as population stratification variables have also
been fit in the model. The approach may even be applied to published results without
access to the original data. In addition, we develop a method to construct accurate
confidence intervals for the OR.
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We illustrate the performance of our approach via extensive simulations of a disease
SNP analyzed by logistic regression. The simulations cover a range of models, disease
allele frequencies, and OR values. Compared to nave OR estimation, our approach pro-
vides greatly reduced bias and mean-squared error, particularly for the modest effect
sizes likely to be encountered in complex diseases. In addition, our confidence inter-
val procedure provides coverage that is accurate or slightly conservative. Performing
simulations for OR values near the null presents a challenge, because significant results
are very rare when applying genome-wide thresholds. We thus employ a screening ap-
proach in which a deterministic trend statistic is used to identify datasets potentially
significant in logistic regression.
2.2 Methods
We assume a genetic model with one parameter for the effect of disease genotype,
which includes recessive, dominant, and additive models. We use β = log(OR) to
denote the true loge odds ratio for disease risk conferred by a referent genotype, or for
the contribution of each allele in an additive model. A single locus test statistic for
disease association can be expressed as an estimate for β divided by an estimate for its
standard error,
z =
βˆ
SˆE(βˆ)
(2.1)
which is compared to the asymptotic null distribution N(0, 1). We will refer to βˆ and
SˆE(βˆ) as na¨ıve estimators, as they are obtained from standard statistical procedures
without acknowledging selection based on significance. For our problem, we wish to
estimate β only when the SNP is significant in two-sided testing, i.e., |z| > c for
a value c corresponding to genome-wide significance. By explicitly considering this
selection, below we obtain three new estimators and a confidence interval procedure.
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Our approach offers marked improvements over βˆ and standard confidence intervals.
Our exposition includes mathematical and motivational details that we believe will
considerably demystify the problem, which has until now appeared more obscure and
complex than necessary. The performance of our new estimators is described in the
Simulations subsection 2.2.8.
2.2.1 Significance bias (the winner’s curse)
When logistic regression is used to test for genetic association, the Wald statistic for
genetic effect assumes the specific form of (2.1), with numerator and denominator
obtained from maximum likelihood and the information matrix (McCullagh and Nelder
1989; Agresti 2007; Cox and Snell 1989). However, the essence of our approach applies
to a wide variety of testing procedures, for which the key requirements typically hold:
(i) asymptotic normality of βˆ, and (ii) consistency of the standard error estimate, so
that SˆE(βˆ)/SE(βˆ) → 1. Expressing the test statistic in the form (2.1) provides a
straightforward illustration of significance bias, and points the way toward corrected
estimation procedures. Related test statistics based on maximum likelihood ratios,
efficient scores, or directly based on contingency tables, are all asymptotically equivalent
to (2.1) for local departures from the null hypothesis H0 : β = 0 (Rao 1973), although
this asymptotic equivalence is not necessary to apply our approach. The remainder of
this subsection is similar to Garner (2007), but our explicit and expanded treatment
provides the grounds for later development.
For large samples, SˆE(βˆ) does not vary markedly in repeated data realizations.
Thus the estimate βˆ and its statistical significance are highly correlated (Garner 2007)
and the problem can be restated as single-parameter estimation for a truncated normal
distribution. To see this, we define µ = β/SˆE(βˆ), with Z
.∼ N(µ, 1). Our use of this
approximation follows from the standard result Z−µ = βˆ−β
SˆE(βˆ)
D→ N(0, 1) for increasing
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sample size (Wald 1943). The statistical procedures to follow are developed entirely
this “µ version” of the problem, which has been greatly simplified by the variance
standardization.
Our na¨ıve estimate of µ is µˆ = z, and the expectation can be shown analytically to
be
Eµ(Z
∣∣|Z| > c) = µ+ φ(c− µ)− φ(c+ µ)
Φ(−c+ µ) + Φ(−c− µ) , (2.2)
where φ and Φ are the density and cumulative distribution function of a standard
normal, respectively (see Appendix A). This is the two-sided rejection version of a
result given by Garner (2007). As we detail in Results (Section 2.3), the bias can be
substantial in realistic settings. In the special case of the null hypothesis µ = 0, it is
clear from (2.2) that the na¨ıve estimate z is unbiased, because the two-sided testing
procedure is equally likely to falsely declare positive or negative risk (i.e., a protective
effect of the referent genotype). It is not clear that the lack of bias for na¨ıve estimation
under the null has been fully appreciated (e.g., Figure 2 in Zo¨llner and Pritchard (2007)
does not display the exact null value). However, this lack of bias requires averaging
over rejections for both positive and negative z. In any significant dataset, µˆ must be
less than −c or greater than c, and so will be far from the truth under the null. In
other words, the lack of bias under the null is offset by very large variance.
2.2.2 An approximate conditional likelihood
The approximating distribution of Z suggests a correspondingly approximate likelihood
for µ,
L(µ) = pµ(z) = φ(z − µ) (2.3)
The likelihood applies generally to a wide variety of testing procedures, eliminating any
nuisance parameters that have been included in the modeling, including stratification
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variables, clinical covariates, or the effects of other SNP genotypes. It is easy to show
that the maximum likelihood estimate (MLE) is µˆ = z. A standard approach to
likelihood testing for H0 : µ = 0 (Wald 1943) involves comparing the maximum log-
likelihood ratio LLR = −2ln(L(µˆ)/L(0)) to a χ21 density. It is also simple to show
that here LLR = z2, so in terms of both estimation and testing, the likelihood simply
recapitulates the initial equation (2.1). The advantage to (2.3), however, is that it
provides a simple and transparent approach to handle the conditioning. Acknowledging
the event that the SNP is declared statistically significant, we have the conditional
likelihood
Lc(µ) = pµ(z
∣∣|Z| > c) = pµ(z)
Pµ(|Z| > c) =
φ(z − µ)
Φ(−c+ µ) + Φ(−c− µ) , (2.4)
Under (2.4), the relationship between numerator and denominator is such that, for a
given z, it is quite possible that the most likely value for µ is in the interval [−c, c],
even though z itself is conditioned to be outside that range.
Using this conditional approximate likelihood we now derive improved estimators
of µ. For any proposed value of µ, we can convert back to the desired log odds ratio
using β = µ SˆE(βˆ), where SˆE(βˆ) is obtained from standard approaches (i.e., does
not consider the significance selection). One remarkable feature of our approach is
that we can apply it to published summary results. To do so, we require only the
significance threshold c, βˆ, and SˆE(βˆ). The standard error, if not provided directly, can
be inferred from c, βˆ, and any one of the following: z, the p-value, or an unconditional
OR confidence interval.
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2.2.3 The conditional MLE
Using the conditional likelihood, the maximum likelihood principle suggests the MLE
estimator,
µ˜1 = arg maxµ Lc(µ),
which can be obtained using numerical maximization for any z and c (hereafter “∼”
will signify estimates based on the conditional likelihood). Note that in this setting
the conditional maximum likelihood estimate provides no guarantee of unbiasedness
or efficiency, a fact that does not appear to have been considered by other investiga-
tors. We have already applied large-sample assumptions in constructing the conditional
likelihood (2.4), but as we show below, other estimators can provide reduced bias or
mean-squared error for certain ranges of µ, and therefore β.
Motivated by bias-reduction, one might attempt to directly correct the bias in µˆ by
solving for µ in the equation Eµ(Z
∣∣|Z| > c) = z. Such an estimator has intuitive appeal,
representing the value of µ for which, after conditioning on significance, we would have
expected to observe z. Perhaps surprisingly, this “bias-correction” estimator in fact
turns out to be µ˜1. To see this, we take the derivative of the conditional likelihood with
respect to µ, for which the identity L′c(µ˜1) = 0 implies
z = µ˜1 +
φ(c− µ˜1)− φ(c+ µ˜1)
Φ(−c+ µ˜1) + Φ(−c− µ˜1) , (2.5)
Comparing equation (2.3) to (2.5) implies that the bias-correction estimator and µ˜1 are
the same. Similar estimators have been examined in the context of sequential clinical
trials, in which effect parameters are estimated only after a stopping boundary has
been reached (Liu et al. 2004). Despite its secondary motivation as a bias-correction
estimator, the conditional MLE µ˜1 is not in fact unbiased, due to nonlinearity in the
bias of the na¨ıve estimator µˆ. Moreover, in this setting the conditional MLE has no
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special optimality properties, and other estimators may be reasonable. Nonetheless, we
will show that µ˜1 is markedly improved over the na¨ıve estimator, both in terms of bias
and mean squared error.
2.2.4 The mean of the normalized conditional likelihood
The motivation to reduce mean-squared error (MSE) suggests another, perhaps less-
obvious estimator,
µ˜2 =
∫∞
−∞ µLc(µ)dµ∫∞
−∞ Lc(µ)dµ
, (2.6)
which is easily calculated numerically. µ˜2 is the mean of the random variable following
the distribution Lc(µ), normalized to be a proper density. µ˜2 has favorable MSE prop-
erties when averaged across a wide range of µ. This fact follows from an interpretation
of µ˜2 as a posterior mean in a Bayesian treatment of the problem with a flat prior on
µ (Leonard and Hsu 1999). However, µ˜2 is considered here as an entirely frequentist
estimate, with bias and error examined at each value of µ and judged accordingly. For
|z| near the boundary c, µ˜2 typically represents a less aggressive shrinkage toward 0
compared to µ˜1.
2.2.5 A compromise estimator
In the treatment below, we will see that the conditional likelihood is typically skewed,
and so µ˜1 and µ˜2 can differ appreciably for certain values of z. µ˜2 can show higher MSE
than µ˜1 for µ near zero, but is more favorable for µ away from zero, while the bias of
µ˜1 and µ˜2 can be of opposite signs for µ near the significance threshold c. Thus as a
practical compromise we also examine the estimator
µ˜3 = (µ˜1 + µ˜2)/2,
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which balances the strengths of µ˜1 vs. µ˜2.
2.2.6 Illustrations of the conditional likelihood
Figure 2.1 illustrates the conditional and unconditional likelihoods assuming an illus-
trative constant threshold c = 5.0. Panels (a)-(c) correspond to z = 5.2, 5.33, and 6.0,
respectively. For each panel, the unconditional likelihood is centered and maximized
at z (indicated by a dot on each plot). For panel (a), when z is only slightly above
the threshold, the conditional likelihood is in contrast shifted aggressively towards zero
(µ˜1 = 0.66, µ˜2 = 2.53, µ˜3 = 1.60). When z is well above the threshold (z=6.0, panel
(c)) this shift is much smaller (µ˜1 = 5.48, µ˜1 = 4.94, µ˜1 = 5.21). For an intermediate z
(panel (b)), the shift is intermediate. Note that our estimates are obtained here for the
µ version of the problem, and the conversion β = µSˆE(βˆ) must be performed before
the results are interpreted on the log-odds scale.
As desired, the conditional likelihood shows a clear shift toward zero. But why
is the shift so extreme, e.g., when z = 5.2? Such a z-value (which is equivalent to
µˆ) has already met genome-wide multiple-testing correction for statistical significance,
but a shrinkage from µˆ = 5.2 to µ˜1 = 0.66 (for example) will effect a corresponding
proportional reduction in the log odds ratio. Thus it seems our proposed estimation
procedures can often adjust the estimated effect size to be practically insignificant. To
see why the result is reasonable, consider that the conditional likelihood, as a frequentist
construction, makes no judgment about the prior plausibility of various values of µ.
When presented with a value z for each µ, it considers only the chance that z would
have arisen, given that |z| > c.
Figure 2.2(d) presents the (truncated normal) conditional densities for z under µ =
0.66 and µ = 5.2. These µ values were chosen because they represent the conditional
and unconditional MLEs when z = 5.2. Note that these curves are conditional densities
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for z, not likelihoods. However, for a fixed value of z, the relative heights of the two
curves reflect the conditional likelihoods for the two competing values of µ. From the
curves we can see the value z = 5.2 is 2.77 times more likely to arise when µ = 0.66 than
when µ = 5.2. Expressed in another way, when µ values are truly of large magnitude,
then z tends to overshoot the threshold c by a greater amount than was observed here
for z = 5.2. Thus in this instance we would conclude that µ is not likely to be of large
magnitude.
Our three proposed estimators can be easily computed numerically, and simple R and
Excel programs to do so are available at our website www.bios.unc.edu/~fwright/
genomebias. Using the threshold c = 5 for illustration, we have calculated the con-
ditional expectations and MSEs for the three estimators, shown in Figure 2.2[(a)-(b)].
The three corrected estimators provide dramatically reduced bias compared to the na¨ıve
estimator for much of the range of µ. For µ = 0, by symmetry all estimators are un-
biased. For |µ| considerably larger than c, all methods will give estimators near z and
will be nearly unbiased. The corrected estimators tend to under-correct for small µ
and over-correct for large µ. The conditional MLE µ˜1 can be viewed as a first-order
attempt to correct the bias, while the data z occupies the same range whether µ is
small or large. In a sense, the corrected estimate splits the difference between the two
extremes, leading to the observed pattern.
The MSE for µˆ = z is extremely large for µ near zero, as predicted. MSEs for
the corrected estimators are considerably smaller in the range of small to moderate
µ. As described above, these estimators are easily converted to the corresponding
improved log(OR) estimators β˜1, β˜2, β˜3. Moreover, for large samples the bias and MSE
properties for µ will largely carry over to real data, essentially with a rescaling of the
axes to convert µ to β.
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Figure 2.1: Behavior of the unconditional and conditional likelihoods for µ.
Unconditional and conditional likelihoods of µ are presented for (a) z = 5.2, (b) z = 5.33
and (c) z = 6. The location of the observed z is indicated by a black dot on each plot.
The conditional likelihood changes considerably for small changes in z near c. For larger
z, the conditional likelihood approaches the unconditional likelihood. Likelihoods for
µ < −c are negligible and not shown. (d): Conditional densities of z for µ = 0.66 and
µ = 5.2, with the relative likelihoods highlighted for a fixed value z = 5.2.
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Figure 2.2: Estimators and confidence intervals for µ with significance thresh-
old c = 5.
(a) The expectation of na¨ıve estimator µˆ shows substantial bias and (b) very large
mean squared error for much of the range of µ, while the corrected estimators have
lower bias and MSE (c) Upper and lower confidence bounds for µ as a function of the
observed statistic z.
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2.2.7 Conditional confidence intervals
Proper interpretation of the corrected µ estimates requires an understanding of esti-
mation error, conditioned on statistical significance. Standard confidence interval (CI)
procedures fail in this setting. For example, after conditioning on significance, a stan-
dard 95% CI for µ cannot contain 0, for otherwise it would not have been significant.
Thus, when µ = 0 the standard CI procedure has zero conditional coverage probability.
Zo¨llner and Pritchard (2007) addressed this issue by using a standard maximum like-
lihood ratio approach applied to the conditional likelihood. In our setting, a 1− η CI
created in this manner would consist of all µ values such that 2ln(Lc(µ˜1)/Lc(µ)) ≤ q1−η,
where q1−η is the 1− η quantile of a χ21 density. However, we have shown via numerical
integration that in the µ version of the problem, the true coverage probability of this
CI procedure can exhibit markedly conservative or anticonservative departures from
1 − η, depending on the true µ. Approaches using the second derivative at lnLc(µ˜1)
to estimate the error variance also fail. The difficulty arises because the conditional
m.l.e is not normally distributed, nor is the shape of Lc(µ) approximately normal for a
realized dataset.
To create confidence intervals with correct conditional coverage, we return to the
original Neymanian concept of a confidence region (Rao 1973; Lehmann and Casella
1983), which can always be applied when the distribution of a test statistic is known
for each value of the unknown parameter. Let A(µ, 1 − η) be an acceptance region
depending on µ such that
Pµ
(
Z ∈ A(µ, 1− η)∣∣|Z| > c) = 1− η .
Given an observed z, the confidence region consists of all values µ such that z ∈ A(µ, 1−
η). It is straightforward to show that this approach gives exact coverage probability
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1 − η for any µ. Among possible acceptance regions, we choose A(µ, 1 − η) as the
interval between the η/2 and 1−η/2 quantiles of the conditional density pµ(z
∣∣|Z| > c).
Note that, although we have presented three competing point estimates for µ, our
procedure yields only a single CI. Figure 2.2 (c) shows the upper and lower confidence
limits for our CI procedure for each z. Note that the limits are wider when |z| is
near c, reflecting less certainty about µ, and can even contain µ = 0. This does not
contradict the statistical significance - the intent of the procedure is to obtain correct
coverage for any µ (including µ = 0) after conditioning on significance. The conversion
of the confidence limits to the β scale is
(
µlowerSˆE(βˆ), µupperSˆE(βˆ)
)
. Although our
procedure is guaranteed correct conditional coverage in the idealized µ setting, our CI
for β relies on large-sample normality assumptions for βˆ. Thus we investigate empirical
coverage of our procedure in the Results Section.
2.2.8 Simulations
To describe our simulations, we begin with basic notation for disease association stud-
ies. We let y denote the disease status (0=control, 1=case) for an individual, and
x denote the SNP genotype predictor value. For a bi-allelic SNP with major allele
A and minor allele a, x is defined as follows for genetic models with respect to a:
Recessive
g =

0, AA
0, Aa
1, aa
Additive
g =

0, AA
1, Aa
2, aa
Dominant
g =

0, AA
1, Aa
1, aa .
20
We assume the logistic model for a randomly sampled individual in the population
log (P (Y = 1|x)/(1− P (Y = 1|x))) = α + βx,
for some α, and β is the log odds ratio for a unit increase in x. Rather than speci-
fying α directly, it is more interpretable to solve for α for a specified allele frequency
and disease prevalence pi. The marginal frequency of x is denoted p(x), and is easily
calculated from Hardy-Weinberg assumptions. With fixed disease prevalence, the iden-
tity pi =
∑
x
exp(α+βx)
1+exp(α+βx)
p(x) was used to calculate α. Finally, solving for the genotype
probabilities conditioned on case/control status yields
P (X = x|Y = 1) = p(x)
pi
exp(α + βx)
1 + exp(α + βx)
and P (X = x|Y = 0) = p(x)
1− pi
1
1 + exp(α + βx)
.
A standard result is that logistic modeling for β applies even when the data are sampled
retrospectively (McCullagh and Nelder 1989).
Each dataset was simulated and analyzed in R v.2.5.1. We will denote the total
sample size n = ncases + ncontrols, and ncases = ncontrols throughout. Most simulations
consisted of n = 1000. This sample size is relatively small for a genome scan, and
was intentionally chosen to emphasize any departures from normality or difficulties in
estimating SE(βˆ). Larger sample sizes were also examined for several of the setups to
examine the effect of sample size on bias, MSE, and confidence coverage. We assumed a
disease prevalence of 0.01 throughout - the retrospective sampling is not very sensitive
to this specification. We examined β ranging from -0.7 (OR ≈ 0.5) to 0.7 (OR ≈ 2).
This range corresponds to biological plausibility for complex disease (Ioannidis et al.
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2001), and ensures that simulations span the range from low power to high power. For
simplicity, we used c = 5.0, corresponding to a single p-value of 5.7 × 10−7, near the
genome-wide threshold considered by others (Zondervan and Cardon 2007; Todd et al.
2007; Scott et al. 2007).
For recessive models we considered MAF values of 0.25 and 0.5 - lower values cre-
ated small expected cell counts that were problematic for sample sizes of 500 in each
group. For the additive and dominant models we considered minor allele frequency
(MAF) values of 0.05, 0.1, 0.25, and 0.5. A single setup consisted of the genetic model,
MAF, and β, and sufficient simulations were performed for each setup to obtain 1000
significant datasets. Setups with β = 0 required on the order of 109 − 1011 simulations
for this rarefied threshold. We sped up the analysis by first applying a chi-square test
(Cochran-Armitage trend test for the additive model) to the datasets, which can be
obtained without iterative maximization. The chi-square statistic was determined to
have a close correspondence to z2 obtained from the more computationally intensive
logistic regression, and a chi-square statistic ≥ 24 was determined to capture essentially
all datasets with z2 ≥ c2 = 25. Datasets meeting the chi-square criterion were analyzed
via logistic regression in R glm. For datasets achieving final significance as determined
by logistic regression, βˆ and SˆE(βˆ) were used to obtain β˜1, β˜2, β˜3, and conditional
confidence intervals.
2.3 Results
In all scenarios described here, expectations and mean-squared errors are calculated
conditional on significance, i.e., |z| > c.
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2.3.1 Bias
The top row of Figure 2.3 plots the means for each of the na¨ıve and corrected estima-
tors vs. β (with corresponding OR values) for all models, with MAF=0.25. The na¨ıve
estimator shows very large bias, especially for moderate β. All of the corrected esti-
mators show dramatically reduced bias across most of the range examined. For each
model, the corrected estimates tend to under-correct for small (magnitude) β while
overcorrecting for large β. All of the methods become nearly unbiased for large β, as
they must, for the conditional and unconditional likelihoods are nearly identical when
|z| is well beyond c. In terms of bias, β˜1 performs best among the corrected estimates
for small . However, the over-correction of the conditional MLE can be substantial for
moderate to large β, especially for the recessive model. β˜2 shrinks the estimates toward
zero less dramatically, resulting in under-correction for a larger part of the range of β.
β˜3 strikes a balance between the other two corrected estimates, and has much improved
bias for moderate β under the recessive model. All estimators are effectively unbiased
for β = 0. A subtle asymmetry in the plots for positive and negative log(OR), most
evident in the recessive model, occurs because MAF< 0.5 and, for a fixed prevalence,
the logistic intercept α depends on β.
2.3.2 Mean squared error
The corresponding MSE values for the estimators are shown in the bottom row of
Figure 2.3. The na¨ıve estimator βˆ exhibits extremely large MSE for most β values
examined. For β this is due to high variance, while for moderate β the na¨ıve estimator
has low variance but high bias. The corrected estimators show dramatically improved
MSE for β in the interval [-0.3, 0.3] (OR ranging from 0.74 to 1.35) that encompasses
the bulk of significant associations thus far for complex diseases (Todd et al. 2007;
Scott et al. 2007). The MSEs of β˜1 and β˜2 are largely complementary. At β = 0 ,
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Figure 2.3: Expectations and mean squared errors for the three genetic mod-
els under MAF=0.25.
For the three models and MAF=0.25, the corrected estimators show greatly improved
performance for much of the range of β. Top row : expected values for the na¨ıve and
conditional likelihood estimators vs. β. Bottom row : mean squared errors for the es-
timators. The y-axes for the MSE plots are rescaled to highlight details - the MSE is
considerably larger for the recessive model due to scarcity of the risk homozygotes.
the MSE(β˜1) is fairly low, while MSE(β˜2) peaks. For larger magnitude β, the roles
reverse. As expected, β˜3 exhibits a more even MSE across the range, and represents
a reasonable choice for stable error characteristics. For the additive and dominant
models, βˆ exhibits very low MSE for large β. This phenomenon is not as attractive as
it appears, essentially resulting from a boundary effect in which βˆ is nearly constant
because z is just barely significant. In particular, for β outside of the plotted range,
m.s.e( βˆ) rises again to the var(βˆ ) value encountered in the unconditional setting.
The empirical bias and MSE observed in our simulations essentially follow the results
from the version of the estimation problem, with a rescaling of the axes to convert µ
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Figure 2.4: Mean squared errors of the estimators vs. β for MAF values
ranging from 0.05 to 0.5.
The additive model is assumed, with n = 1000. The MSEs drop for larger MAF, but
the relative performance of the estimators is maintained.
to β. Our empirical results for the remaining MAF values are plotted in Supplemental
Figure 2.6, and largely follow the results described for MAF=0.25. Figure 2.4 shows
a portion of these results for the additive model, in which the MSE is shown to drop
for all estimators as the MAF increases. This occurs because for small MAF the MSE
is largely driven by the heterozygote genotype counts, which increase with the MAF.
The key point of Figure 2.4 is that the relative advantages of the corrected estimators
are preserved across a wide range of MAF values.
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Figure 2.5: Estimates of the CI coverage probability plotted against β for the
three genetic models, MAF=0.25.
Black dots correspond to 95% CIs, grey dots to 90% CIs. The dashed curves represent
coverage of standard 95% CIs which do not acknowledge the significance selection. Top
row : n = 1000 (500 cases and 500 controls). Bottom row : n = 2000 (1000 cases and
1000 controls). Coverage is close to nominal, except for regions of over-coverage in the
recessive model due to small cell counts (note that the y-axis range begins at 0.7). For
all models, the coverage will approach the nominal value as the sample size increases
further.
2.3.3 Confidence coverage
Figure 2.5 presents the estimated coverage probabilities of 95% and 90% CIs with
MAF=0.25 for the three models. The top row shows the results for n = 1000. The
coverage is close to the nominal level for almost all the setups, except for conservative-
ness near β = 0 for the recessive model. The coverage of the na¨ıve confidence intervals
is also depicted in the Figure, dropping dramatically out of the axis range to zero cov-
erage for β of small magnitude. For n = 2000, the coverage of the proposed procedure
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improves further, with a region of modest over-coverage for recessive models. Results
for other MAF values are similar, and are presented in Supplemental Figure 2.7.
2.3.4 Sample sizes, thresholds, and covariates
Our setup conditions represent a wide range of realistic scenarios, but cannot represent
all situations and complicating factors. Fortunately, the large-sample behavior of the
constructed approximate likelihood provides considerable robustness for our conclu-
sions. Supplemental Figure 2.8 shows the results of increasing sample size for several
realistic β values for the additive model when MAF=0.25. The bias and MSE for all the
estimators are reduced as the sample size increases. For each sample size, the corrected
estimators show superior bias and MSE compared to the na¨ıve estimator.
In maximum likelihood settings, the distribution of the Wald test statistic is largely
driven by β/SE(βˆ). This is also true for our conditional likelihood, because β/SE(βˆ)
determines the non-centrality of the z-statistic. For a fixed ratio ncases : ncontrols,
the standard error is proportional to 1/
√
n. Thus, for the setups in Figure 2.3 and
Supplemental Figure 2.6, a doubling of the sample size to n = 2000 (for example, and
assuming cases and controls remain in the same ratio) would produce qualitatively
similar results, with perhaps a slight improvement for the corrected estimates as the
normality approximation improves. Moreover, we can make the results quantitatively
comparable by appropriate rescaling. For example, for any value β for n = 1000,
the comparable results for n = 2000 should correspond to β′ = β
√
2. Supplemental
Figure 2.9(a) demonstrates an empirical example of this effective rescaling equivalence
for the additive model, MAF=0.25. Thus the conclusions from our simulations extend
to larger sample sizes.
Similarly, variations on the threshold c do not have much impact. A value of c = 5.5
would be considered quite conservative for genome scans, corresponding to Bonferroni
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control of family-wise error at 0.05 for 1.3 million SNPs. Empirical investigation re-
quires many more simulations to achieve significance, but we find that the qualitative
behavior of the estimators is unchanged (Supplemental Figure 2.9(b))
Finally, we simulated an example in which the additive model is fit (MAF=0.25),
and the logistic regression includes an additional continuous covariate (distributed
N(0, 1), one fitted regression coefficient) and a discrete covariate (distributed Bino-
mial(2,0.05), two fitted coefficients). The covariates were independent of case-control
status and the test-locus genotype. The Wald statistic is relatively insensitive to in-
clusion of these extra parameters, and the relative change in degrees of freedom quite
minimal. Accordingly, the results for our corrected estimators are virtually unchanged
compared to the model without covariates (Supplemental Figure 2.9(c) - only β˜1 is
shown). Covariate considerations are increasingly important in genome scans, for ex-
ample to control for confounding population stratification.
2.3.5 Analyses of published datasets
Tables 2.1, 2.2, and 2.3 illustrate our re-analysis of three published genetic association
studies: an association study with a modest number of SNPs (Table 2.1), as well as
two GWAS (Tables 2.2 and 2.3), all of which had been analyzed using additive models.
We begin with a brief description of the three studies, followed by our re-analysis. In
Table 2.1, we present the analysis results of Yu et al. (2007) who re-examined the
lymphoma dataset described in Wang et al. (2005). They used 48 SNPs and a p-value
threshold of 0.1/48 ≈ 0.002. We report the standard OR results and the bootstrap bias-
corrected estimates produced by Yu et al. (2007), as well as the estimates from a larger
pooled analysis involving seven studies (Rothman et al. 2006). The SNPs rs1800629
and rs909253 were found to be significant, with ORs 1.54 and 1.40, respectively. In
Table 2.2 we list four significant SNPs reported by Todd et al. (2007) resulting from
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two Type 1 diabetes (T1D [MIM 222100]) GWAS studies, declaring SNPs as significant
if they have p-values less than 5× 10−7. We also display the results from a larger case-
control followup study conducted by Todd et al. (2007) to confirm their results. In
Table 2.3 we report the results of a GWAS by Scott Scott et al. (2007), who performed
numerous analyses of several Type 2 diabetes (T2D [MIM 125853]) datasets (FUSION,
DGI, and WTCCC/UKT2D). We consider here only the SNPs reported by the T2D
authors using the declared genome-wide significance threshold (p < 5 × 10−8) for the
combined analysis of all studies.
Using only the published odds ratios, p-values and stated significance thresholds, we
produced bias-corrected odds ratios for all of these studies. Our corrected β estimates
are exponentiated to obtain odds ratios: for example, ˜OR1 = exp(β˜1). For the two
lymphoma SNPs (Table 2.1), the p-values are slightly above the threshold, and our
bias-corrected estimates shrink the na¨ıve OR estimates markedly. Our estimated values
match well with the bootstrap-corrected values obtained by Yu et al. (2007), as well as
the pooled analysis results from Rothman et al. (2006).
For the four T1D SNPs (Table 2.2), our analysis results in noticeably less extreme
OR estimates than that reported by Todd et al. (2007). The corrected ORs and CIs
for the most extreme SNP, rs17696736, are only slightly changed from the published
estimated of 1.37 because the result is so extreme (p = 7.27 × 10−14). However, the
followup study obtained a considerably lower value (OR=1.16), with the 95% CI not
overlapping the earlier estimates, suggesting possible heterogeneity in population sam-
pling. For the two least significant T1D SNPs among those considered, the corrected
ORs show a more substantial change. It is worth noting that the OR estimate corre-
sponding to the SNP rs12708716 was shrunk from 0.77 to about 0.82 by our, methods
while the estimated OR from the follow-up was 0.83. We also note that for the four
significant T1D SNPs, as well as an additional three SNPs approaching significance
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(Table 1 of Todd et al. (2007)), the followup study always gave a less extreme OR es-
timate than the initial studies. This result is strong empirical evidence for significance
bias, and that corrected OR approaches are needed.
Table 2.3 gives the results for the combined T2D studies. All of the p-values are con-
siderably beyond the significance threshold, and so the corrected estimates are nearly
unchanged from the original estimates. This phenomenon is hopeful, in the sense that
with very large studies OR estimates can be attained that will not be shrunk to irrele-
vance by corrected OR estimates.
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Table 2.3: Original vs. corrected odds ratio estimates for published genetic association
study III: GWAS of T2D, Scott et al. (2007) (9521 cases and 12183 controls)
aStandard OR values as reported
bCorrection method proposed in this manuscript
SNP P-value Reported ORa, Bias-corrected estimates Biasb-
(95% CI) corrected
O˜R1 O˜R2 O˜R3 (95% CI)
rs7903146 1.0x10−48 1.37 1.37 1.37 1.37 (1.31,1.43)
(1.31,1.43)
rs4402960 8.9x10−16 1.14 1.14 1.14 1.14 (1.10,1.18)
(1.11,1.18)
rs10811661 7.8x10−15 1.2 1.2 1.2 1.2 (1.14,1.26)
(1.14,1.25)
rs8050136 1.3x10−12 1.17 1.17 1.16 1.16 (1.10,1.22)
(1.12,1.22)
rs7754840 4.1x10−11 1.12 1.11 1.1 1.11 (1.05,1.16)
(1.08,1.16)
rs5219 6.7x10−11 1.14 1.13 1.12 1.12 (1.06,1.19)
(1.10,1.19)
rs1111875 5.7x10−10 1.13 1.11 1.1 1.1 (1.02,1.17)
(1.09,1.17)
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2.4 Discussion
We have presented an approach that greatly reduces significance bias for odds ratios in
genome association scans, and is much simpler than competing approaches. We favor
the use of β˜3 as a general-purpose estimator with fairly uniform MSE as a function of β.
However, all of the three corrected estimators have greatly superior performance to the
na¨ıve estimator. Although developed for case-control applications, our methodology
is an effective blueprint to perform inference whenever a Wald-like statistic has been
used to declare significance. Thus the general approach can be used in numerous
other settings, including regression-based quantitative trait association analyses. Our
results are qualitatively similar to those of other investigators (Yu et al. 2007; Zo¨llner
and Pritchard 2007) (e.g., see bias curves similar to ours in Figure 2 of Zo¨llner and
Pritchard (2007)). Additional comparisons to these approaches should be performed in
future work, although comparison is complicated by differing genetic models. To our
knowledge, our approach is the only method that can perform bias correction based
only on published summary tables.
The widespread application of conditional likelihood estimators in genome scans
will no doubt be discouraging to genetic investigators, who may expend considerable
time and expense only to find that a significant SNP is estimated to have a very weak
effect. Nonetheless, we view this process as healthy and necessary for the genetics
community, and in particular to tamp down expectations that significant findings will
be easily replicated. The use of our estimators may also have an additional benefit of
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discouraging excessive massaging of data and trying various test procedures to achieve
genome-wide significance. If a SNP suddenly becomes significant after numerous data
manipulation procedures have been applied, its z-statistic is likely to be only slightly
above the threshold c. Thus, as we observed in the µ version of the problem, the
conditional likelihood estimator will be dramatically shrunk towards the null. Thus
the estimated SNP effect size will be very modest, as is appropriate here for a likely
spurious finding.
Our current approach does not explicitly consider multi-stage or other sequential
designs, in which SNPs meeting a loose standard of significance are used for further
testing in a follow-up sample. However, for multistage designs in which almost all
SNPs that will eventually be declared significant are carried forward to later stages, the
approach may be used directly. Also, our results technically hold for a SNP randomly
selected from those achieving the significance threshold, and thus an additional bias
may be anticipated for the most highly significant SNPs among a collection of significant
SNPs. Although we believe this second source of bias is much less than that produced
by significance selection, it is the subject of continuing investigation.
Our rejection-sampling scheme was feasible, but required a massive number of sim-
ulations to provide accurate results. Future work in this area may benefit from the
practical development of importance sampling or related computational techniques to
provide flexible and accurate simulations conditioned on significance.
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2.5 Web Resources
The URLs for data presented herein are as follows: Online Mendelian Inheritance
in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/. R code and a simple Ex-
cel calculator to perform our method are available at www.bios.unc.edu/~fwright/
genomebias.
2.6 Supplemental Figures
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Figure 2.6: Expected values and mean squared errors for the estimators for
the three models.
MAF values are 0.05, 0.1, and 0.5 for additive and dominant models, and MAF=0.5
for recessive models.
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Figure 2.7: Estimates of the CI coverage probability plotted against β for the
three genetic models.
Various MAF values are shown (for recessive models, only MAF=0.5 is depicted).
Black dots correspond to 95% CIs, grey dots to 90% CIs. The dashed curves represent
coverage of standard 95% CIs which do not acknowledge the significance selection. First
page, n = 1000. Second page, n = 2000.
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 Figure 2.8: Expected values and the mean squared errors of the estimators
for the additive model with MAF=0.25.
The results are plotted against sample size, for β = 0, 0.18, and 0.34, corresponding to
OR values 1.0,1.2, and 1.4.
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Figure 2.9: Properties of the corrected estimators extended to additional set-
tings.
Throughout this figure we use the additive model, MAF=0.25, and n = 1000 except
where noted. (a) Expectations of β˜1 vs. β (plotted points) for n = 1000, overlaid with
results for the same estimator vs. β
√
2 (dashed line) for n = 2000. The close correspon-
dence is a consequence of the unifying treatment in terms of µ. (b) Expectations of the
estimators for c = 5.5 show that the qualitative behavior is similar to the behavior for
c = 5.0. (c) Inclusion of both a discrete (2 degree-of-freedom) and a continuous (1 d.f.)
covariate in the logistic regression modeling has essentially no effect on the behavior of
our estimators.
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Chapter 3
Analysis of Secondary Phenotypes
in Case-control Studies
3.1 Introduction
Genome-wide association studies (GWAS) require a lot of investment in terms of effort,
time, and money. So it is only natural for investigators to want to make maximum use
of the data collected in the process of conducting a GWAS. Usually in GWAS the
primary research question is identification of SNPs influencing susceptibility to a trait
that is of interest. In the process, information on a host of other phenotypes, typically
correlated with the primary phenotype, is collected. Subsequent to the initial detection
of SNPs significant for the disease phenotype, researchers often want to analyze the
secondary phenotypes for efficient use of data and also to supplement the primary
analysis (Frayling et al. 2007; Weedon et al. 2008; Gudbjartsson et al. 2008; Lettre et al.
2008; Weedon et al. 2007; Sanna et al. 2008; Loos et al. 2008). In fact, data for the
analysis of a phenotype may come from several GWAS, for which data were originally
collected with different research objectives in mind. Because of its efficient design, data
for GWAS are usually case-control sampled. In such cases the data cannot be considered
as a random sample from the population and ignoring the the ascertainment on the
basis of the primary phenotype can produce biased estimate of the association between
a SNP and a secondary phenotype (Nagelkerke et al. 1995). For the appropriate analysis
of secondary phenotype we have to take into consideration the biased sampling.
There are several options for handling the secondary analysis for case-control data
(Jiang et al. 2006), such as a) ignore the sampling mechanism, b) analyze controls
only, c) analyze cases only, d) include the disease status as an explanatory variable,
e) apply weighted approach, or f) implement maximum likelihood methods. The first
method of analyzing the combined sample of cases and controls without accounting
for the ascertainment can lead to a severely biased estimate of the risk effect for the
secondary phenotype. For case-control data, prospective analysis ignoring the sampling
scheme yields valid estimate of the odds ratio for disease risk, but the same reasoning
does not hold for the secondary phenotype generally (Nagelkerke et al. 1995). Only
under very restrictive conditions, prospective analysis will give unbiased estimate of
the population measure of association between the SNP and the secondary phenotype.
Nagelkerke et al. (1995) suggest using only the controls for the secondary analysis. This
method is approximately valid if the disease is rare. If we analyze only the cases or
the controls, then we loose a lot of information. For methods b), c), and d), adjusting
for the disease status eliminates the possibility of bias induced by the case-control
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sampling mechanism, but the estimates that we derive from each of these methods
may be estimating quantities very different from the one that we are interested in.
For example, including the disease phenotype as a covariate is a convenient way of
incorporating the sampling mechanism in the analysis but not necessarily the true
model that we believe in. Monsees et al. (2009) have recently discussed in details the
situations under which the na¨ıve analysis that ignores the ascertainment or the analysis
that includes disease status as a covariate are valid.
The standard survey approach or Horvitz-Thompson approach uses weights in-
versely proportional to the selection probabilities (Jiang et al. 2006; Scott and Wild
2002). Richardson et al. (2007) describe it as a stratum-weighted logistic regression for
a binary secondary phenotype and compare its merits with the usual practice of adjust-
ing for the disease status by including it in the regression as a covariate. It is, of course,
necessary to have knowledge of the sampling fractions for cases and controls, which we
do for nested case-control studies. But for population-based case-control studies, this
information is not readily available. Rather than focus on the absolute sampling frac-
tions, we can try to estimate from external information, such as the prevalence, the
ratio of the the sampling fractions which would be sufficient for the purpose of weighted
regression.
An alternative approach to secondary analysis is to use the retrospective likelihood
(Jiang et al. 2006; Scott and Wild 1997, 2001a, 1991; Lee et al. 1997; Lin and Zeng
2008) which conditions on the disease status. To work with the retrospective likelihood
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one needs to model the joint distribution of the primary and the secondary pheno-
types given the genotype and other covariates. The joint distribution can be factorized
further into the marginal distribution of the secondary phenotype and the conditional
distribution of the primary phenotype given the secondary phenotype. Our interest
lies in estimating the parameters of the marginal distribution of the secondary phe-
notype given the genotype and the covariates. As Jiang et al. (2006) have described,
we can either treat the conditional distribution of the primary phenotype given the
secondary phenotype non-parametrically or we can model it as a logistic regression.
Lin and Zeng (2008) have developed likelihood methods for analysis of both binary and
continuous secondary traits where they have modeled the the conditional distribution
of the primary phenotype given the secondary phenotype as a logistic regression. An
alternative way to specify the joint model is to parametrically model the marginals of
the primary and the secondary phenotypes and also build a parametric model for their
association given the genotype and the covariates. The distribution of the genotype
and the covariates is a nuisance parameter in the retrospective likelihood. It is difficult
to parameterize the covariate distribution and is usually treated non-parametrically.
We describe a method to analyze secondary phenotypes, both binary and continu-
ous, where we model the joint distribution of the phenotypes such that the marginals
for each phenotype respect the commonly used models for analyzing them separately.
Or in other words, we specify the joint distribution such that the marginal distribution
for the disease phenotype is always logistic and that for the secondary phenotype is
logistic or linear depending on whether it is binary or continuous respectively. We have
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allowed for inclusion of covariates in our models and have performed extensive simu-
lations to compare the performance of our proposed approach with the performances
of the na¨ıve method of prospectively analyzing the combined sample of cases and con-
trols ignoring the biased sampling, case-only analysis, controls-only analysis, and the
weighted method.
3.2 Methods
Let D denote the disease phenotype (0=control, 1=case), Y the secondary phenotype,
and G the SNP genotype. Let Z denote the vector of covariates in the model, such
as gender, age, or environmental factors. The secondary phenotype, as well as the
covariates, may be either dichotomous or continuous. The data were sampled from
the population with respect to the disease status variable D. We are interested in the
association between the secondary phenotype Y and the SNP genotype G, adjusting
for the covariates Z. The appropriate likelihood that takes into account the case-
control sampling mechanism is the retrospective likelihood P (Y,G, Z|d). For case-
control sampled data (di, yi, gi, zi), i = 1, 2, . . . , n, the retrospective log-likelihood is
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l = logL
=
n∑
i=1
logP (Y = yi, G = gi,Z = zi|di)
=
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ) +
n∑
i=1
logP (G = gi,Z = zi)
−
n∑
i=1
logP (D = di) .
For prospectively collected data, we can make inference about θ from
∑n
i=1 logP (D =
di, Y = yi|gi, zi;θ) and ignore P (G = g,Z = z). But, for case-control data, we cannot
ignore P (G = g,Z = z) since it is intertwined with θ in
P (D = d) =
∑
y
∑
g
∑
z
P (D = d, Y = y|g, z;θ)P (G = g,Z = z) .
The retrospective likelihood, therefore, is a function of θ, the parameter of interest,
and P (G = g,Z = z), the nuisance parameter. We assume that disease prevalence is
known approximately and incorporate that information in the likelihood. Under known
prevalence, say P (D = 1) = Π, we maximize
l =
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ) +
n∑
i=1
logP (G = gi,Z = zi)
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with respect to (θ, P (G = g,Z = z))′ subject to the constraint
∑
y
∑
g
∑
z
P (D = 1, Y = y|g, z;θ)P (G = g,Z = z) = Π . (3.1)
We assume that G and Z are independent in the population. Since G is discrete and
can take at most three values, we treat the probability distribution of G, p(g), as
a nuisance parameter and maximize the likelihood with respect to it, subject to the
constraint
∑
g p(g) = 1. It is generally difficult and unreasonable to parameterize the
covariate distribution P (Z = z). If all the covariates are categorical and there are
tractable number of combinations of the levels of the covariates, then we can treat
them as nuisance parameters and maximize the likelihood with respect to them. For
illustration purpose, let us consider the situation where the genotype is coded as 0 or
1 with P (G = 1) = δ and we have a single binary covariate, Z, with probability of
success ψ. Then we maximize
l(θ, δ, ψ) =
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ) + nG1 log δ
+(1− nG1) log (1− δ) + nZ1 logψ + (1− nZ1) log (1− ψ) , (3.2)
where nG1 =
n∑
i=1
gi and nZ1 =
n∑
i=1
zi ,
with respect to (θ, δ, ψ)′ subject to the constraint (3.1) to get the maximum likelihood
estimate of θ. The MLE is consistent and asymptotically normal and the covariance
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matrix of the MLE can be consistently estimated by the inverse of the observed informa-
tion matrix. This method becomes infeasible very quickly as the number of covariates
increases and it does not allow for continuous covariates. For continuous covariates we
can assume the profile likelihood approach (Lee et al. 1997; Wild 1991; Lin and Zeng
2008; Scott and Wild 2001b). Suppose Z is now a continuous covariate. We have n
parameters P (Z = zi) = pi, i = 1, . . . , n describing the distribution of Z. To get the
maximum likelihood estimate of θ we need to maximize
l(θ, δ, p1, . . . , pn) =
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ)
+
n∑
i=1
logP (G = gi) +
n∑
i=1
log pi
with respect to (θ, δ, p1, . . . , pn)
′ subject to the constraints
∑n
i=1 pi = 1 and
∑
y
1∑
g=0
n∑
i=1
P (D = 1, Y = y|g, zi;θ)P (G = g)pi = Π .
Using Lagrange multipliers, we maximize
l(θ, δ, pi, . . . , pn)
=
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ)
+
n∑
i=1
logP (G = gi) +
n∑
i=1
log pi + λ1(
n∑
i=1
pi − 1)
+λ2
(∑
y
1∑
g=0
n∑
i=1
P (D = 1, Y = y|g, zi;θ)P (G = g)pi − Π
)
(3.3)
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with respect to (θ, δ, pi, i = 1, . . . , n)
′. λ1 and λ2 are determined using the constraints.
Maximizing(3.3) with respect to pi we get,
1
pi
− λ1 − λ2
∑
y
1∑
g=0
P (D = 1, Y = y|g, zi;θ)P (G = g) = 0 . (3.4)
Multiplying the above equation by pi on both sides and then taking a sum over i we
get,
λ1 = n− λ2Π .
Substituting λ1 in (3.4), we have
pi =
(
n− λ2Π + λ2
∑
y
1∑
g=0
P (D = 1, Y = y|g, zi;θ)P (G = g)
)−1
.
Thus, the profile log-likelihood for (θ, δ)′ is
lprofile(θ, δ) =
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ) +
n∑
i=1
logP (G = gi)
−
n∑
i=1
log
(
n− λ2Π + λ2
∑
y
1∑
g=0
P (D = 1, Y = y|g, zi;θ)P (G = g)
)
,
where λ2 is determined by
n∑
i=1
(
n− λ2Π + λ2
∑
y
1∑
g=0
P (D = 1, Y = y|g, zi;θ)P (G = g)
)−1
= 1 .
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The estimates from the profile likelihood are consistent and asymptotically normal and
the covariance matrix can be consistently estimated by the inverse of the observed
information matrix obtained from the profile likelihood. We propose an alternative
approach that has been used in various contexts: the pseudo likelihood idea put forward
by Gong and Samaniego (1981) for parametric inference and later extended by Hu and
Lawless (1997) to a semiparametric setting. The idea involves maximizing the pseudo
likelihood Lp
(
θ, p(g), Pˆ (Z = z)
)
, where Pˆ (Z = z) is a nonparametric estimate of
P (Z = z). Under known prevalence the pseudo log-likelihood lp is
lp = logLp
(
θ, p(g), Pˆ (Z = z)
)
=
n∑
i=1
logP (D = di, Y = yi|gi, zi;θ) +
n∑
i=1
logP (G = gi)
along with the constraint
∑
y
∑
g
∑
z
P (D = 1, Y = y|g, z;θ)P (G = g)Pˆ (Z = z) = Π .
Noting that
P (Z = z) = P (Z = z|D = 1)P (D = 1) + P (Z = z|D = 0)P (D = 0) ,
we estimate P (Z = z) by
Pˆ (Z = z) = Pˆ (Z = z|D = 1) Pˆ (D = 1) + Pˆ (Z = z|D = 0)
(
1− Pˆ (D = 1)
)
,
52
where Pˆ (Z = z|D = i) , i = 0, 1 are valid estimates being the empirical cumulative
distribution functions based on the controls and the cases respectively. For Pˆ (D = 1)
we have to depend on external information. The pseudo maximum likelihood esti-
mate(MLE) is then obtained by maximizing the pseudo log-likelihood, lp,with respect
to the parameter of interest, θ, and the nuisance parameter, p(g). A rigorous devel-
opment of the the asymptotic properties of the pseudo MLE is complicated. Hu and
Lawless (1997) discuss the asymptotics for pseudo likelihood methods in the context
of response-related missing covariates. Following the same lines we plan to lay down
the details of the asymptotic theory for pseudo likelihood estimation in our situation.
We now discuss how to parameterize the joint distribution (D, Y |g, z) for binary and
continuous secondary phenotypes.
3.2.1 Binary secondary phenotype
There are several ways to parameterize the bivariate distribution (D, Y |g, z). For di-
chotomous Y we are interested in models for which the marginal distributions of D
and Y given g and z are both logistic. The bivariate logistic model, considered by
Palmgren (1989), is one such model that has been used before in this context (Jiang
et al. 2006; Lee et al. 1997) and is conceptually very simple. It is based on the fact
that the joint distribution of two binary variables can be specified in terms of their
marginal probabilities and their odds ratio. Thus, for a randomly sampled individual
in the population we specify the joint distribution of D and Y given g and z as:
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logit P (D = 1 | g, z) = α1 + β1g + γ1′z
logit P (Y = 1 | g, z) = α2 + β2g + γ2′z
logOR(D, Y | g) = P (D = 1, Y = 1 | g, z)P (D = 0, Y = 0 | g, z)
P (D = 1, Y = 0 | g, z)P (D = 0, Y = 1 | g, z) = α3 + β3g .
The pseudo log-likelihood is, therefore, a function of θ = (α1, β1,γ1, α2, β2,γ2, α3, β3)
′,
the parameter of interest, and p(g), the nuisance parameter. With fixed disease preva-
lence, the identity
P (D = 1) =
∑
z
∑
g
exp(α1 + β1g + γ1
′z)
1 + exp(α1 + β1g + γ1′z)
p(g)Pˆ (Z = z) (3.5)
is used to compute α1 given (β1,γ1, α2, β2,γ2, α3, β3)
′ and p(g). Thus, the retrospective
pseudo log-likelihood, under known prevalence, is
lp =
n∑
i=1
logP (D = di, Y = yi|gi, zi) +
n∑
i=1
logP (G = gi) ,
which is a function of θ = (β1,γ1, α2, β2,γ2, α3, β3,γ3)
′, and p(g). We obtain the
pseudo MLE of θ by maximizing lp with respect to (θ, p(g))
′. We can write down
the joint probabilities piij = P (D = i, Y = j|g, z) , i, j = 0, 1 in terms of the marginal
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probabilities pii. = P (D = i|g, z) and pi.j = P (Y = j|g, z), and the odds ratio ψ = pi11pi00pi10pi01 ,
pi11 =

1
2
(ψ − 1)−1
{
a−√(a2 + b)} , ψ 6= 1
pi1.pi.1 , ψ = 1 ,
where a = 1 + (pi1. + pi.1)(ψ− 1) and b = −4ψ(ψ− 1)pi1.pi.1. The rest of the piijs can be
derived from pi11 and the marginals.
3.2.2 Continuous secondary phenotype
For continuous Y , we consider joint models for (D, Y |g, z) such that the marginal
distribution of D given g and z follows a logistic regression model and the marginal
distribution of Y given g and z is normal, that is,
logit P (D = 1 | g, z) = α1 + β1g + γ1′z
and Y | g, z ∼ N (α2 + β2g + γ2′z, σ22) .
We introduce two levels of latency to come up with a joint model which satisfies the
above conditions. We assume that the disease status variable, D, is derived from
thresholding a latent continuous variable, U , whose marginal density given g and z is
logistic with location parameter µ1 = α1 + β1g + γ1
′z and scale parameter 1, that is,
p
U|G,Z(u | g, z) =
exp (−(u− µ1))
(1 + exp (−(u− µ1)))2 ;−∞ < u <∞
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and D =

1, U ≥ 0
0, U < 0
.
⇒ P (D = 1 | g, z) = exp (µ1)
1 + exp (µ1)
.
In order to connect U with Y we introduce another latent variable V . We assume that
U is derived by transforming a continuous variable, V , whose marginal distribution
given g and z is normal with mean µ1 and variance 1, and that (V, Y |g, z) follows
bivariate normal. The required transformation is U = µ1 + log
Φ(V−µ1)
1−Φ(V−µ1) . Thus, we
specify the following population model for the bivariate response (D, Y |g, z),
 V
Y
∣∣∣∣ g, z ∼ N

 µ1
µ2
 ,
 1 ρσ2
ρσ2 σ
2
2

 , where
µ1 = α1 + β1g + γ1
′z , µ2 = α2 + β2g + γ2′z , and ρ = α3 + β3g .
Let U = µ1 + log
Φ(V−µ1)
1−Φ(V−µ1) and D =

1, U ≥ 0
0, U < 0
.
Assuming disease prevalence to be known, the retrospective pseudo log-likelihood is a
function of θ = (β1,γ1, α2, β2,γ2, σ2, α3, β3)
′, and p(g),
lp =
n∑
i=1
logP (D = di, Y = yi|gi, zi) +
n∑
i=1
logP (G = gi) ,
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where the identity
P (D = 1) =
∑
z
∑
g
exp(α1 + β1g + γ1
′z)
1 + exp(α1 + β1g + γ1′z)
p(g)Pˆ (Z = z) (3.6)
is used to compute α1 given θ and p(g). We obtain the pseudo MLE of θ by maximiz-
ing lp with respect to (θ, p(g))
′. The joint probability of the primary and secondary
phenotypes given g and z can be expressed as
P (D = d, Y = y|g, z)
= P (Y = y|g, z)P (D = d|y, g, z)
=
1
σ2
φ
(
y − µ2
σ2
)
{dP (D = 1|y, g, z) + (1− d) (1− P (D = 1|y, g, z))} ,
P (D = 1|y, g, z) = Φ
 ρσ2 (y − µ2)− Φ−1
(
1
1+exp (µ1)
)
√
1− ρ2
 .
3.2.3 Simulation
We perform extensive simulations to compare the performance of our likelihood method
with 1) the na¨ıve method that involves including the disease status variable as a covari-
ate in the regression for Y on g and z, 2) cases-only analysis, 3) controls-only analysis,
and 4) weighted regression. We are interested in estimating the effect of the genotype
on the secondary phenotype, adjusting for the covariates. So β2 is our main parameter
of interest and we judge the different estimators of β2 on the basis of bias and mean
squared error (MSE). We fix the sample size at 3000, 1500 cases and 1500 controls, for
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each dataset that we analyze. We consider a SNP with dominant mode of inheritance
for both primary and secondary phenotypes and a minor allele frequency of 0.25. The
population is assumed to be in Hardy-Weinberg equilibrium. We perform simulations
for both binary and continuous secondary phenotypes. We examine β1 and β2 across
the range -0.6 (OR=0.55) to 0.6 (OR=1.82). This grid corresponds to a biologically
plausible range of values for complex diseases and helps us understand how these pa-
rameters affect bias and variance of the estimates. The γ coefficients are drawn at
random from N(0, 1). α1 is derived such that the disease prevalence is 0.05. For the
binary secondary phenotype, a prevalence of 0.2 is used. For parameterizing the asso-
ciation between the primary and the secondary phenotypes given the genotype and the
covariates, we used α3 = log(9) and β3 = 0. For the continuous secondary phenotype,
we set α2 = 1, σ2 = 1, α3 = 0.6, and β3 = 0.
We present two sets of simulations. The first set corresponds to a single binary
covariate with probability of success 0.45. In the second set of simulations we add
another covariate, a continuous one which is normally distributed and independent of
the binary covariate. So each simulation setup is indexed by the number of covariates:
one or two, the nature of the secondary phenotype: binary or continuous, and the
pair (β1, β2), We replicated 1000 datasets for each simulation setup. For the first set
of simulations we parameterize the covariate distribution by the probability of success
of the binary covariate and maximize the likelihood with respect to it, as described in
Methods 3.2. In the second set of simulations we apply the pseudo likelihood approach.
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3.3 Results
Figures 3.1 and 3.2 present simulation results for a single binary covariate. Figure
3.1 corresponds to a binary secondary phenotype and Figure 3.2 is for a continuous
secondary phenotype. Figures 3.3 and 3.4 depict simulation results when we have two
covariates, one binary and the other continuous. For a binary secondary phenotype we
have Figure 3.3 and for the continuous case we have Figure 3.4.
3.3.1 One binary covariate
We have plotted the means and the MSEs of the estimators of β2 against β1 for different
values of β2. The first column of Figure 3.1 shows the means and the second column
depicts the MSEs. The different rows correspond to different values of β2. For each
plot the estimators are denoted by different plotting symbols and color: the magenta
crosses are for the retrospective likelihood, the black pluses correspond to the na¨ıve
method, the red solid circles are for the case-only analysis, the green ones correspond
to the controls-only analysis, and the blue triangles are for the weighted method.
The first column of Figure 3.1 shows the means of the estimators of β2. The na¨ıve
estimator shows very large bias. It overestimates for positive values of β1 and underesti-
mates for negative values of β1. There is almost no difference in bias for the estimators
derived by considering only the case or the control populations. Both these methods
have smaller bias than the na¨ıve method but the direction of bias is opposite. The
weighted estimator and the MLE are effectively unbiased for all values of (β1, β2). All
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the methods become nearly unbiased when both β1 and β2 are zero, i.e., the SNP is not
associated with either phenotype. As we decrease the value of β2 from zero, the values
of β1 for which the biases in the na¨ıve, the cases-only, and the controls-only estimators
are almost reduced to zero also decrease. Similarly, as β2 slides from zero in the positive
direction, the values of β1 for which the three estimators are unbiased also slides in the
positive direction, but it is difficult to predict which particular combination of β1 and
β2 would give us practically unbiased estimators for these three methods.
The second column of Figure 3.1 shows the MSEs of the estimators of β2. The na¨ıve
estimator exhibits large MSE for most of the grid of (β1, β2) values. The MSE drops
remarkably when the na¨ıve estimator is almost unbiased but it is difficult to characterize
the parameter values for which it happens. The cases-only analysis has lower MSE than
the controls-only analysis for the (β1, β2) values examined. The weighted estimator and
the MLE exhibit a even performance across the range of β1, the MLE having slightly
lower MSE throughout than the weighted estimator. Both of them have smaller MSE
than the na¨ıve, the cases-only, and the controls-only estimators for most of the grid.
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Figure 3.1: Means and MSEs for binary secondary phenotype with one covariate
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When the secondary phenotype is continuous the bias and the MSE of the estimators
do not depend on the value of β2. So for Figure 3.2 we have only a single row of plots
displaying the means and the MSEs of the estimators plotted against β1. The left and
the right plots show the means and the MSEs respectively. From the left plot we see
that the estimator derived from the cases has extremely large bias while the controls-
only estimator is remarkably less biased. The bias for the na¨ıve estimator lies between
those of the cases-only and the controls-only estimators but is opposite in direction.
The weighted estimator and the MLE are virtually unbiased. All the estimators are
nearly unbiased when β1 is zero, i.e., when the SNP is not associated with the disease.
The corresponding MSE values for the estimators suggest that the MLE has the lowest
MSE for almost all β1 values examined. The estimator derived from the case population
has the highest MSE, followed by the na¨ıve estimator. The weighted estimator has a
low MSE throughout the β1 range, but it is slightly higher than that for the MLE. The
MSE of the estimator based on the control population is marginally higher than the
MSE for the weighted approach.
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Figure 3.2: Means and MSEs for continuous secondary phenotype with one covariate
3.3.2 One binary and one continuous covariate
Figures 3.3 and 3.4 display the means and the MSEs of the estimators obtained via
pseudo likelihood approach in the case where we have two covariates: one binary and
one continuous. Figure 3.3 shows how the means and the MSEs of the estimators change
according to the values of β1 and β2 when we have a binary secondary phenotype. The
plots in the first column of Figure 3.3 displaying the means of the estimators are
similar in pattern to the plots in the first column of Figure 3.1 where we had only
one covariate. However, the difference between the estimators obtained from the cases
and the controls separately is pronounced here: the case-only estimator is clearly more
biased than the controls-only estimator. The na¨ıve estimator exhibits extremely large
bias. The pseudo MLE and the weighted estimator reduce bias significantly compared
to the na¨ıve estimator and are nearly unbiased throughout the grid. The corresponding
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MSE plots are displayed in the second column of Figure 3.3. The pseudo MLE exhibits
a low MSE across the entire grid. Even though the weighted estimator has a even
performance across the β1 range, it has a higher MSE than pseudo MLE throughout.
The cases-only estimator has smaller MSE than the controls-only estimator for most
the the (β1, β2) values examined. The na¨ıve estimator exhibits very large MSE values,
especially for large values of β1 and β2. MSE of the na¨ıve estimator drops below all the
other estimators for a short range of β1 values for each value of β2. This is due to the
fact that the na¨ıve estimator is very close to the true parameter value in this range,
but as mentioned before, it is difficult to characterize these (β1, β2) combinations where
the na¨ıve estimator performs well.
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Figure 3.3: Means and MSEs for binary secondary phenotype with covariates
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Figure 3.4 displays the means and the MSEs of the estimators, when we have a
continuous secondary phenotype, plotted against β1. We see that adding a continuous
covariate and applying pseudo likelihood approach almost affected no change in the
means and the MSEs of the estimators and Figure 3.4 is almost the same as Figure 3.2.
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Figure 3.4: Means and MSEs for continuous secondary phenotype with covariates
3.4 Discussion
We have presented an approach for appropriate analysis of secondary phenotypes for
case-control data, the disease status being the primary phenotype. We have assumed
a retrospective likelihood approach to analyzing the data. Our method provides for
both binary and continuous secondary phenotypes. We have used the Palmgren model
(Palmgren 1989) to specify the joint distribution of the primary and the secondary
phenotypes when the secondary phenotype is binary. For the continuous case, we have
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suggested a novel bivariate model involving two latent variables. This joint model
is such that the marginals of the primary and the secondary phenotypes follow the
distributions that are conventionally used to analyze them separately. We have pro-
vision for including covariates, both binary and continuous, in the analysis. We have
discussed in detail how to handle the covariate distribution and have introduced the
pseudo likelihood approach for easier implementation of our method.
There are several ways of analyzing the secondary phenotype, a few of them are
ad hoc and the rest more formal, as pointed out by Jiang et al. (2006). The na¨ıve
method of ignoring the sampling scheme, methods involving analyzing only the cases
or the controls, and the method that conditions on the disease status by including it in
the regression are generally considered as ad hoc and it is not definitely known under
which circumstances they will provide valid estimates of the association between the
genotype and the secondary phenotype. Lin and Zeng (2008) provide a detailed critique
of the standard methods. However, their theoretical conclusions are applicable for the
conditional model that they have assumed to be true. It is difficult to predict how any
of these methods would behave if we were to believe in any other population model for
the joint distribution of the primary and the secondary phenotypes.
The likelihood approach and the weighted approach have theoretical justifications.
The likelihood method involves the retrospective likelihood. We can work with the
retrospective likelihood in several ways depending on how we decide to model the
population and also how we parametrize it. Also, there are many options for handling
the covariate distribution. The weighted approach, on the other hand, is free of any
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modeling assumption. It is simple, fast, and easy to implement. But it is usually less
efficient than the likelihood method as we have also seen in our simulations. With only
two covariates in the model, it had higher MSE than the pseudo MLE. Moreover, with
the weighted method there is no way of exploring the relationship between the primary
and the secondary phenotypes. The likelihood method provides us with estimates and
standard errors of the parameters specifying that relationship.
Pseudo maximum likelihood estimation was first proposed by Gong and Samaniego
(1981) in the parametric set up. Later Hu and Lawless (1997) applied it for problems
with response-related missing covariates where they replaced an unknown distribution,
the nuisance parameter for the problem, in the likelihood with its empirical estimate.
For their problem they have presented in details the asymptotic theory and also es-
timates of the asymptotic variance of the pseudo MLE. The use of pseudo likelihood
estimation in our case would allow us a great amount of flexibility and would obviate
the need for explicitly dealing with the covariate distribution. It also makes the imple-
mentation very fast. But as a cost for this flexibility, the variance of the pseudo MLE
is not the inverse of the negative Hessian matrix as is usually the case for likelihood
methods or even profile likelihood methods. The variance of the pseudo MLE is com-
plicated because of the nuisance parameter and the uncertainly involved in estimating
it. Future work in the area of secondary analysis for case-control data would benefit
from the development of the asymptotic theory of pseudo MLE and estimate of the
asymptotic variance of the pseudo MLE for our problem.
It is important to understand the behavior of the different estimators to be able to
68
predict whether in a particular situation they would provide valid estimates or not. We
need to develop theoretical properties of the estimators to be able to understand the
direction of their bias. It is also required to understand how the different parameters
such as prevalence, association between the genotype, and the primary and secondary
phenotypes, the association between the two phenotypes, or the MAF affect the bias
and the MSE of the estimators and would have important implications for future work
in this area.
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Chapter 4
Significance Bias for Secondary
Phenotypes and GXE Interaction
4.1 Introduction
The primary purpose of genome-wide association studies (GWAS) is identification of
SNPs influencing susceptibility to complex traits. Since, in modern whole genome scans,
usually hundreds of thousands of SNPs are genotyped, thresholds in the range 10−7 −
10−8 are generally used for point-wise significance (Todd et al. 2007; Zondervan and
Cardon 2007; Scott et al. 2007). Using the original data for estimation purpose coupled
with the application of stringent thresholds, distorts the estimation process, producing
inflated estimates of effect sizes. After detection, genetic effect of the significant SNPs
are estimated based on the same data. This phenomenon (commonly referred to as the
“winner’s curse” (Lohmueller et al. 2003; Zo¨llner and Pritchard 2007) or “significance
bias” (Ghosh et al. 2008)) has profound importance for estimation of genetic effects
and is well documented in the literature (Zo¨llner and Pritchard 2007; Ghosh et al. 2008;
Garner 2007; Go¨ring et al. 2001; Siegmund 2002; Sun and Bull 2005; Yu et al. 2007).
A related problem arises for risk estimation of secondary effects, such as secondary
phenotypes or gene-environment interactions, when the secondary analysis is restricted
to SNPs that are found to be significant in the primary analysis. Such secondary bias
can be substantial but has received no attention so far in the GWAS literature. If
the biased results are used for the design of follow-up studies, they are likely to be
underpowered, relying on an inflated estimate of effect size. The variance of the risk
estimates may also be affected.
Most genetic studies gather information on a host of variables besides the disease
status, the primary phenotype. Subsequent to the initial detection of the SNPs sig-
nificant for the primary phenotype, estimation of the impact of these SNPs on other
correlated traits is of interest (Frayling et al. 2007). The well-known phenomenon of
significance bias which affects the estimation of the disease risk effect also distorts the
estimation of the effect of the significant SNP on correlated phenotypes. Also, the
sampling design followed is of critical importance in deciding the analysis procedure
for the secondary trait. GWAS commonly employs case-control design to collect data
on a range of qualitative and quantitative variables and usually standard logistic or
linear regressions, ignoring the case-control sampling mechanism, are applied for the
secondary analysis. It has been proved that only under very restrictive conditions,
these analyses methods would yield unbiased estimates of the population parameters of
interest (Nagelkerke et al. 1995). Hence, for the analysis of secondary traits, sampling
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bias (Nagelkerke et al. 1995; Lee et al. 1997; Lin and Zeng 2008) adds to the problem of
significance bias in case-control sampled data. We have presented a detailed discussion
of existing methods for secondary analysis of case-control data and have developed a
retrospective likelihood method in Chapter 3 that we use for analysis in this chapter.
Interplay of genes and environmental factors contribute to the susceptibility to com-
plex traits. After a SNP is identified, researchers are often interested in estimating the
gene-environment interaction effect. Since this estimation is performed conditional on
the fact that the SNP has been found significant for the disease phenotype, significance
bias can be a major concern for the estimation of gene-environment interaction effect.
Results exploring the phenomenon of significance bias for estimation of interaction
effect have received very little attention in the GWAS literature.
Significance bias for estimation of the primary effect, i.e., the disease risk effect, and
ways of reducing it or eliminating it has been investigated in detail in many publica-
tions (Garner 2007; Ghosh et al. 2008; Go¨ring et al. 2001; Siegmund 2002; Sun and Bull
2005; Yu et al. 2007; Zo¨llner and Pritchard 2007). While the problem of significance
bias is well appreciated in the context of disease phenotype, it has not yet been ex-
plored for analyses of secondary effects, be it effect size for additional phenotypic trait
or gene-environment interaction. We have recently proposed a conditional likelihood
approach (Ghosh et al. 2008), based on the estimate of genetic effect and its standard
error, to correct for the bias in effect size estimation for disease risk in case-control
association studies. We propose an extension of the conditional likelihood approach to
the multivariate setting where multiple effect coefficients are simultaneously estimated.
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For implementing this method we need the na¨ıve estimates of the primary and sec-
ondary effect sizes and an estimate of the covariance between the na¨ıve estimates. We
provide formulas for estimating the covariances for different sampling scenarios. We
prove that, under certain conditions, estimation of the gene-environment interaction
effect conditional on the significance of the marginal effect of the SNP is not affected
by significance bias. However, after a SNP is found significant in a logistic regression
involving gene, environment, and their interaction, if we wish to estimate the inter-
action effect, the estimation may be distorted by significance bias. In that case, our
proposed method can be applied to provide bias-reduced estimates of the interaction
effect.
We illustrate the performance of our approach via extensive simulations. The sim-
ulations cover a biologically plausible range of disease effect sizes. We show results
for both prospective and retrospective sampling schemes. Compared to the na¨ıve esti-
mation ignoring the selection based on significance, our approach provides remarkably
reduced bias and mean-squared error. The results have considerable importance for
the proper analysis of secondary effects, and in the design of follow-up studies.
4.2 Methods
We assume a genetic model for disease risk that includes among other covariates, a
single SNP with either recessive, dominant, or additive mode of inheritance. We use
β1 = log(OR1) to denote the primary effect: the true log odds ratio for disease risk
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conferred by a referent genotype or by each allele as in an additive model, adjusting for
other covariates in the model. A single locus test statistic for the primary effect can be
expressed as an estimate for β1 divided by an estimate for its standard error,
Z1 =
βˆ1
SˆE(βˆ1)
,
which is compared to its asymptotic null distribution N (0,1). Let β−1 =

β2
...
βp

denote the vector of true log odds ratios attributable to the secondary effects such as the
effects of the SNP on secondary phenotypes or the effect of SNP-environment interaction
on disease risk. Our goal is to estimate β−1 only when the SNP is significant for the
disease in two-sided testing, i.e., |z1| > c for a value c corresponding to genome-wide
significance. We will refer to βˆ−1, obtained from standard statistical procedures without
acknowledging this selection of the SNP based on significance prior to estimation, as
the na¨ıve estimator. We have recently reported an approximate conditional likelihood
approach to estimate β1 conditional on the SNP being significant for disease association
(Ghosh et al. 2008). We have shown that our method offers marked improvements over
the na¨ıve estimation procedure. We extend the concept of explicitly considering the
selection in formulating the likelihood to the multivariate setting and propose three
new estimators.
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4.2.1 Significance bias
Estimation of β−1 can be restated as a mean-parameter estimation problem for trun-
cated multivariate normal distribution with known variance-covariance matrix. To see
how, we define β =
 β1
β−1
, βˆ =
 βˆ1
βˆ−1
, and Z =
 Z1
Z−1
where Z−1 =

Z2
...
Zp
with Zi =
βˆi
SˆE(βˆi)
. βˆis and SˆE(βˆi)s are obtained from maximum likelihood and
the information matrix. From the standard result

βˆ1−β1
SˆE(βˆ1)
βˆ2−β2
SˆE(βˆ2)
...
βˆp−βp
SˆE(βˆp)

→D N (0,R) with increasing sample size,
where R = corr(βˆ) =
 1 ρ
′
ρ R22
 , it follows that Z .∼ N (µ,R) , µ =
 µ1
µ−1

where µ−1 =

µ2
...
µp
with µi =
βi
SˆE(βˆi)
. A consistent estimate of R can be obtained
from the likelihood theory. For the ease of mathematical discourse, we assume that it
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is known. The conditional density of Z given |Z1| > c is:
pµ(z| |Z1| > c) = pµ(z)
P (|Z1| > c)
=
Np(z;µ,R)
Φ(−c− µ1) + Φ(−c+ µ1) ,
where |z1| > c, −∞ < zi < ∞, i = 2, . . . , p, −∞ < µi < ∞, i = 1, . . . , p, and Φ is the
cumulative distribution function of a standard normal. The statistical exposition to
follow is based entirely on this “µ-version” of the problem. It is evident that, in the “µ-
version”, the problem boils down to estimation of µ from pµ(z| |Z1| > c): a truncated
multivariate normal density with mean µ and known variance-covariance matrix.
Our na¨ıve estimate of µ based on pµ(z) is µˆ = z, and the expectation can be shown
analytically to be (see Appendix B, section B1)
Eµ (Z| |Z1| > c) = µ+
 1
ρ
 φ(c− µ1)− φ(c+ µ1)Φ(−c− µ1) + Φ(−c+ µ1) , (4.1)
where φ is the density function of a standard normal. It is clear from (4.1) that the
bias incurred in na¨ıve estimation of µ−1 is ρ times the bias in µˆ1, thus being the same
for different values of µ−1. Equation (4.1) illustrates the phenomenon of significance
bias and implies that in the special case of the null hypothesis µ1 = 0 being true, the
na¨ıve estimates are unbiased.
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4.2.2 An approximate conditional likelihood
The approximate asymptotic distribution of Z, approximate since µ is not truly a
parameter, suggests the following approximate likelihood for µ,
L(µ) = pµ(z) = Np(z;µ,R) .
The above likelihood applies to a wide variety of settings, being free from any nuisance
parameters that may have been included in the model, such as other clinical covariates,
stratification variables, or the effects of other SNP genotypes. The maximum likelihood
estimate (MLE) from the above likelihood is µˆ = z. By explicitly considering the fact
that the SNP has been found significant, we have the approximate conditional likelihood
Lc(µ) = pµ(z| |Z1| > c) = Np(z;µ,R)
Φ(−c− µ1) + Φ(−c+ µ1) .
We develop three improved estimators for µ based on this approximate conditional
likelihood. For any proposed µˆ we can easily convert back to βˆ using βˆi = µˆiSˆE(βˆi).
Hence, for estimation of µ we require only the significance threshold c, βˆ, and ˆV ar(βˆ).
4.2.3 The conditional MLE
The conditional likelihood suggests, as one possible solution, the MLE, given by
µ˜(1) = arg maxµ Lc(µ) ,
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which can be obtained by maximizing the conditional likelihood with respect to µ1 and
µ−1 separately, and then solving for them simultaneously. Hereafter “∼” will signify
estimates based on the conditional likelihood.
∂
∂µ1
Lc(µ) = 0 ⇒ ∂
∂µ1
{
φ( z1−µc
σc
)
Φ(−c− µ1) + Φ(−c+ µ1)
}
= 0
⇒ z1 − µc
σ2c
=
φ(−c+ µ1)− φ(c+ µ1)
Φ(−c− µ1) + Φ(−c+ µ1) , (4.2)
where µc = µ1 + ρ
′
R−122 (z−1 − µ−1) and σ2c = 1− ρ′R−122 ρ.
∂
∂µ−1
Lc(µ) = 0 ⇒ ∂
∂µ−1
Np−1
(
z−1; µ−1 + ρ(z1 − µ1),R22 − ρρ
′
)
= 0
⇒ z−1 = µ−1 + ρ(z1 − µ1) . (4.3)
Substituting (4.3) in (4.2) we have,
z1 − µ1 = φ(c− µ1)− φ(c+ µ1)
Φ(−c− µ1) + Φ(−c+ µ1) . (4.4)
We solve for µ1 from (4.4) and plug it in (4.3) to get µ˜
(1)
1 and µ˜
(1)
−1, respectively. Lc(µ)
lends itself to the above mathematical treatment because it can be expanded as
Lc(µ) =
Np−1(z−1;µ−1,R22)φ(
z1−µc
σc
)
Φ(−c− µ1) + Φ(−c+ µ1) , (4.5)
or as
Lc(µ) =
φ(z1 − µ1)Np−1
(
z−1;µ−1 + ρ(z1 − µ1),R22 − ρρ′
)
Φ(−c− µ1) + Φ(−c+ µ1) . (4.6)
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(4.5) uses the conditional density of Z1 given Z−1 and (4.6) uses the conditional density
of Z−1 given Z1. The maximum likelihood estimator is not unbiased. This motivates
us to explore other probable estimators. The moments estimator obtained by solving
Eµ (Z| |Z1| > c) = z for µ is one such possibility. Such a “bias-correction” estimator
has intuitive appeal, representing the value µ for which the truncated multivariate
normal distribution would be expected to generate z. Surprisingly, the maximum like-
lihood estimator and the moments estimator are the same. Comparing and combining
Eµ (Z| |Z1| > c) = z, (4.1), (4.3), and (4.4), we arrive at the above conclusion.
4.2.4 The mean of the normalized conditional likelihood
The motivation to reduce mean squared error (MSE) suggests another estimator,
µ˜(2) =
∫
µLc(µ)dµ∫
Lc(µ)dµ
.
We can think of µ˜(2) as the mean of the random variable following the distribution
Lc(µ), normalized to be a proper density. However, the multivariate integration after
some simplification boils down to obtaining µ˜
(2)
1 as the mean of the random variable
following the distribution Lc(µ1) =
φ(z1−µ1)
Φ(−c−µ1)+Φ(−c+µ1) , normalized to be a proper density,
and then plugging it in z−1 − ρ(z1 − µ˜(2)1 ) to get µ˜(2)−1 (see Appendix B, section B2).
Thus, 
µ˜
(2)
1 =
∫
µ1Lc(µ1)dµ1∫
Lc(µ1)dµ1
µ˜
(2)
−1 = z−1 − ρ(z1 − µ˜(2)1 )
.
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4.2.5 A compromise estimator
The conditional likelihood Lc(µ) is typically skewed, as a result µ˜
(1) and µ˜(2) may differ
appreciably for certain values of z. Thus, as a practical compromise we also examine
the estimator
µ˜(3) = (µ˜(1) + µ˜(2))/2 ,
which balances the strengths of µ˜(1) and µ˜(2).
4.2.6 Secondary phenotype
We performed several simulations to assess our proposed bias-correction method for
secondary phenotypes. To describe our simulations, we begin with the notation. Let d
denote the disease status (0=control, 1=case), y the secondary phenotype value, and
g the genotype predictor value for an individual. For a biallelic SNP with major allele
A and minor allele a, g is defined as follows for different genetic models with respect to a,
Recessive
g =

0, AA
0, Aa
1, aa
Additive
g =

0, AA
1, Aa
2, aa
Dominant
g =

0, AA
1, Aa
1, aa .
Logistic regression of D on g is used to test for disease association, and once the SNP
is found to be significant for the disease, effect of the SNP on the secondary phenotype
is of interest. For simulation purposes, we consider a binary secondary phenotype and
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assume a logistic model for the the conditional distribution of Y given g. The marginal
distribution of G is denoted by p(g), which, given the minor allele frequency, is deriv-
able from Hardy-Weinberg equilibrium. We jointly model the bivariate response (D, Y )
given g. There are several ways to parametrize the bivariate distribution (D, Y |g). We
consider only those models for which the marginal distributions of D and Y given g
are both logistic. The bivariate logistic model, considered by Palmgren (1989), is one
such model and is conceptually very simple. It is based on the fact that the joint distri-
bution of two binary variables can be specified in terms of their marginal probabilities
and their odds ratio. Thus, for a randomly sampled individual in the population we
specify the joint distribution of D and Y given g as:
logit P (D = 1 | g, z) = α1 + β1g + γ1′z
logit P (Y = 1 | g, z) = α2 + β2g + γ2′z
logOR(D, Y | g) = P (D = 1, Y = 1 | g, z)P (D = 0, Y = 0 | g, z)
P (D = 1, Y = 0 | g, z)P (D = 0, Y = 1 | g, z) = α3 + β3g .
For data collected prospectively, use of separate logistic regressions for D and Y
is “valid” in the sense that the estimates obtained from the analysis are consistent
estimates of the corresponding population parameters. For case-control data, a logistic
modeling for β1 applies. However, for the secondary analysis, ordinary logistic regres-
sion of Y on g to infer about β2 is not necessarily valid. For appropriate analyses of
the secondary phenotypes we refer to the retrospective likelihood method described in
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Chapter 3.
Each dataset was simulated and analyzed in R v.2.5.1. We considered a sample of
size n = ncases + ncontrols = 3000, and for retrospective sampling, we assumed ncases =
ncontrols = 1500. We assumed a disease prevalence of 0.18 and a MAF value of 0.25
throughout. We fixed β2 at 0.3, the bias-correction approach is not sensitive to this
specification, as is suggested by equation (4.1). We used c = 5.0 corresponding to a
p-value of 5.7x10−7, near the genome scan threshold considered by others (Scott et al.
2007; Todd et al. 2007; Zondervan and Cardon 2007). We simulated data only under the
dominant mode of inheritance. We fixed the prevalence for the secondary trait at 0.2
and examined β1 ranging from -0.7 (OR ≈0.5) to 0.7 (OR ≈ 2). This spans the range
of biologically plausible values for complex diseases. We used α3 = log 9 and β3 = 0.
For each value of β1 enough simulations were performed to guarantee 1000 significant
datasets. The null and near-null scenarios required massive simulation, on the order
of 1010 for some scenarios, to obtain sufficient number of rejections, i.e., significant
datasets. We initially vetted datasets using chi-square statistics before performing
logistic regression of D on g. Datasets meeting the criteria: chi-square statistic value
≥ 24.5 were used to capture datasets with z21 ≥ c2 = 25. Finally, datasets achieving
z21 ≥ c2 = 25 were analyzed to obtain the parameter estimates, standard errors, and an
estimate of the correlation between the parameter estimates. These estimates are then
used to calculate β˜
(1)
2 , β˜
(2)
2 , and β˜
(3)
2 . Analytical derivation for formulae used to obtain
covariance estimates are provided in Appendix B, section B3.
82
4.2.7 Gene-environment interaction
Our bias correction approach can also be applied for estimation of gene-environment
interaction effect subsequent to finding the SNP significant. Let e denote the environ-
ment predictor value (0=not exposed, 1=exposed). We assume the following logistic
model for a randomly sampled individual in the population,
logit P (D = 1 | g, e) = β(b)0 + β(b)G g + β(b)E e+ β(b)GEge .
If we wish draw inference on β
(b)
GE conditional on the gene being significant in two-sided
testing, i.e., |zG| = βˆ
(b)
G )
SˆE(βˆ
(b)
G )
> c, then parameter estimates of the genetic effect and
the gene-environment interaction effect, and an estimate of the correlation between the
two estimates, as provided by any standard statistical software, will be sufficient to
implement the bias-correction approach. For simulation purposes, we generated data
prospectively from the above model with βg ranging from -0.7 (OR ≈0.5) to 0.7 (OR
≈ 2). We fixed βe and βge at 0.3 and 0.2 respectively. We considered a biallelic SNP
with dominant effect on the disease phenotype. We fixed disease prevalence at 0.01, the
threshold c at 5, and considered a MAF of 0.25. We compared the na¨ıve estimator of
the gene-environment interaction effect, βˆge, with the conditional m.l.e. β˜ge. However,
the usual practice is to first fit a logistic model of D on g only, and if the gene is
found significant, then, a full model involving gene, environment, and their interaction
follows. We demonstrate analytically that, cov(βˆ
(s)
G , βˆ
(b)
GE) = 0, where βˆ
(s)
G is the estimate
of the genetic effect obtained from fitting a logistic regression of D on g only. Detailed
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derivation is provided in the Appendix B, section B4. Hence, for prospective data, the
gene-environment interaction effect estimated from the full model subsequent to the
SNP being found significant for the disease in the gene-only model, is not affected by
significance bias.
4.3 Results
In all the simulation scenarios described here, expectations and MSEs are calculated
conditional on significance. All of them are plotted against β1 with corresponding odds
ratio values.
4.3.1 Secondary phenotype
Figures 4.1 and 4.2 display the simulation results for the secondary phenotype. Figure
4.1 plots the means of the the na¨ıve and corrected estimators. The corresponding MSE
plots are shown in Figure 4.1.
Bias
The first column of Figure 4.1 plots the means for the na¨ıve and corrected estimators
for β1. The na¨ıve estimator shows very large bias, especially for small to moderate β1.
The corrected estimators show dramatically reduced bias for most β1 values examined,
although, they tend to undercorrect for small β1 and overcorrect for large β1. All
the estimators are nearly unbiased for large values of β1. β˜
(1)
1 performs best among
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the three corrected estimators for small β1, but shrinks aggressively for moderate to
large β1 resulting in overcorrection. β˜
(2)
1 shrinks much less dramatically resulting in
undercorrection. β˜
(3)
1 strikes a balance between the two. We notice that the magnitude
of bias in all the estimators is less for case-control data than that for data collected
prospectively. A possible explanation is that the standard error for data collected
prospectively would tend to be bigger than that for data collected retrospectively,
resulting in bigger bias. However rescaling of the axes demonstrates their inherent
similarity in the “µ−version”. The second column of Figure 1 plots the means for the
na¨ıve and corrected estimators for β2. The bias results for β2 essentially follow the same
pattern as β1. Though less dramatic, the corrected estimators show greatly reduced bias
for much of the range of β1. The corrected estimators preserve their relative advantages
over one another. As before, β˜
(1)
2 reduces the bias appreciably for small β1, whereas,
β˜
(2)
2 would be preferred for moderate to large β1. β˜
(3)
2 exhibits a more even performance
across most of the range examined. The plots under the two sampling scenarios would
match up with a rescaling of the axes.
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Figure 4.1: First column: expected values for the na¨ıve and the conditional likelihood
estimators of β1. Second column: expected values for the na¨ıve and the conditional
likelihood estimators of β2.
Mean squared error
The first column of Figure 4.2 shows the MSE values for the estimators of β1. The
na¨ıve estimator exhibits extremely large MSE for most of the range considered. The
corrected estimators offer marked improvement over the na¨ıve estimator, especially for
small β1. The m.s.es of β˜
(1)
1 and β˜
(2)
1 are largely complementary, and β˜
(3)
1 performs
evenly across the range. The second column presents the corresponding plots for β2.
The MSE plots for β2 preserve the relative merits of the corrected estimators compared
to the na¨ıve estimator. For small to moderate β1, the corrected estimators show major
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improvement over the na¨ı estimator. At β1 = 0, the MSE of the na¨ıve estimator is more
than twice the MSE for any of the corrected estimators, this is due to high variance of
the na¨ıve estimator at β1 = 0. For moderate β1 the na¨ıve estimator has low variance
but high bias, again resulting in higher MSE than that for corrected estimators. For all
the sampling scenarios, β˜
(3)
1 represents a reasonable choice for most β1 values examined
here.
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Figure 4.2: First column: mean squared errors for the na¨ıve and the conditional like-
lihood estimators of β1. Second column: mean squared errors for the na¨ıve and the
conditional likelihood estimators of β2.
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4.3.2 Gene-environment interaction
Figure 4.3 displays the simulation results for the gene-environment interaction effect.
The top row of Figure 4.3 plots the means for the the na¨ıve estimator and the bias-
reduced estimator, β˜
(1)
2 , against βg (with corresponding OR values). The left plot
corresponds to the effect of the gene on disease risk, βg, and the right plot is for the
gene-environment interaction effect. The na¨ıve estimators show extremely large bias
specially for moderate values of βg. β˜
(1)
2 reduces bias dramatically for most of the βg
values examined. Both the estimators are nearly unbiased for large βg values. β˜
(1)
2
tends to under-correct for small values of βg while over-correcting for large values of
βg. Both the na¨ıve estimator and the conditional m.l.e. are practically unbiased at
βg = 0. The bias occurs in opposite direction for the gene effect and the interaction
effect. The corresponding MSE plots are shown in the bottom row of Figure 4.3. The
MSE plots for the gene effect and the interaction effect are very similar in pattern. The
na¨ıve estimator shows extremely large MSE for most values of βg. β˜
(1)
2 has remarkably
improved MSE for most of the range considered.
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Figure 4.3: Top row: expected values for the na¨ıve and the conditional likelihood
estimators of βg and βge. Bottom row: mean squared errors for the na¨ıve and the
conditional likelihood estimators of βg and βge.
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4.4 Discussion
We have investigated significance bias for secondary effects and we have proposed an
approach to obtain corrected estimates with remarkably less bias and mean-squared er-
ror than the na¨’ive estimates. We recommend β˜
(3)
2 since it exhibits an even performance
for all β1 values considered. However, all three corrected estimators show substantial
improvement over the na¨ıve estimator. We have described a valid secondary analyses
method for case-control data. We have explored the nature of significance bias for gene-
environment interaction effect and have clarified conditions under which the estimate
of the interaction effect would not be affected by significance bias.
Secondary analyses are very common for GWAS where data are collected on a variety
of phenotypic traits, both quantitative and qualitative. For estimation of genetic effects
of a SNP significant for the disease on additional secondary phenotypes, significance
bias would produce biased estimates of effect sizes. The magnitude of bias would
depend on the correlation between the estimates of the disease risk effect and the effect
sizes of the significant SNP on the secondary phenotypes. For our particular simulation
setup the correlation was modest, hence the results were not as dramatic as those for
disease risk effect, β1. But even for such modest correlation, the MSEs for the corrected
estimators were a few times less than that for the na¨ıve estimator, specially for small
disease risk effect sizes.
For genome scans data are usually collected retrospectively, being cost-effective
and an efficient use of resources. But case-control samples are not representative of the
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population, resulting in selection bias. The semiparametric approach of Lee et al. (1997)
is applicable only if the sampling fractions for the two stratum are known, which in
most cases are not. The likelihood approach by Lin and Zeng (2008) can be performed
for both binary and continuous secondary phenotype, but the joint modeling involves
a slightly restrictive model, referred to as “conditional” model (Lee et al. 1997), where
the odds ratio between the disease phenotype and the secondary phenotype given the
genotype is independent of the genotype. Also, the marginal distribution of D given g
is not logistic. The bivariate logistic model formulation is a fully-parametrized model
and lends itself to the common belief that the the marginal distribution of the disease
status variable given the genotype is logistic.
Inference on β2 is not complete without a confidence interval. Standard confidence
interval(CI) procedures, carried out without acknowledging the selection of the SNP
based on significance, perform very poorly in this setting. To see this, we revert to the
µ-version of the problem. After conditioning on significance, a standard 95% CI for
µ1 cannot contain 0. Thus, when the null hypothesis µ1 = 0 is true, the coverage of
standard CI for µ1 is 0, which in turn throws the standard CI preocedures for µ−1 off
balance. Let us consider the bivariate version of the problem,
 Z1
Z2
 ∼ N2

 µ1
µ2
 ,
 1 ρ
ρ 1

 .
We wish to find a 1 − η CI for µ2 taking into account that |z1| > c has been already
observed. The simplest CI for µ2 will be µ˜2± q1− η
2
√
1− ρ2 where µ˜2 = z2− ρ(z1− µ˜1),
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and q1− η
2
is the 1 − η
2
quantile of the standard normal distribution. Alternatively, we
can construct a profile likelihood for µ2, normalize it to be a proper density, then take
its η
2
and 1 − η
2
quantiles to be the upper and lower confidence limits for µ2. We can
also integrate the joint likelihood over µ1, normalize it to be a proper density, and then
take its η
2
and 1 − η
2
quantiles to be the upper and lower confidence limits for µ2. We
plan to apply these CI procedures to the simulation setup described earlier and judge
their performance. Although we believe that these procedures will perform well, a more
principled confidence interval construction for µ2 is worth investigating.
Our current simulations cover only the dominant mode of inheritance. For additive
model, the retrospective likelihood would involve two nuisance parameters and stability
of the estimates obtained from standard optimization techniques might be an issue.
Also, we have always considered models with only one parameter for the genetic effect.
Future work extending our approach to a more general setup would be important. It
would be interesting to investigate whether joint modeling of the correlated phenotypes
is better than the marginal logistic regression even when both yield valid estimates of
the population parameters of interest.
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Chapter 5
Variable Selection via a Conditional
Likelihood-based Penalty
5.1 Introduction
Consider the linear regression model
y = Xβ +  (5.1)
where the response y is a nx1 vector and the design matrix X is of order nxp. So the
data consists of (yi,xi), i = 1, . . . , n where yi is the response and xi = (xi1, . . . , xip)
′ is
the vector of predictor values for the ith observation in the sample. Let i, i = 1, . . . , n
be independently and identically distributed as N(0, σ2). We assume, without loss of
generality, that the predictors are standardized and the response is centered so that∑
i xij = 0,
∑
i x
2
ij = 1, j = 1, . . . , p, and
∑
i yi = 0.
In the linear regression setup, our goal is to find a linear model that provides a con-
cise description of how the predictors affect the response. The model selection problem
entails selecting variables that might best describe that relationship, and estimating
the coefficients corresponding to those variables. With the simultaneous advent of
high-speed computing and high-throughput technologies, most of the recent research
problems involve datasets with large number of predictors, especially high-dimensional
datasets with fewer observations than predictors. For example, a typical gene expression
data has tens of thousands of genes (predictors) and only a few hundred arrays (obser-
vations). High-dimensional data arise in various fields of scientific research including
computational biology, finance, biomedical imaging, satellite imagery, and many oth-
ers. High-dimensional datasets present a challenge to traditional methods of model
selection and underline the importance of model selection techniques.
We usually judge the usefulness of a predictive model on the basis of prediction ac-
curacy and interpretability. Prediction accuracy is a quantitative measure for assessing
model fit. We can calculate the expected prediction error, also known as test error or
generalization error (Hastie et al. 2001), of a regression fit Xβˆ at X = x′0,
EPE(x0) = E
[
(x′0β + 0 − x′0βˆ)2
]
= σ2 +
[
E(x′0βˆ)− x′0β
]2
+ E
[
x′0βˆ − E(x′0βˆ)
]2
= σ2 +Bias
2 + V ariance .
The first term is the irreducible error part and it cannot be avoided even if β was
94
known. The second and the third components can be controlled and they make up
the mean squared error of x′0βˆ. The second term is the squared bias: the amount
by which the average of the estimate differs from x′0β; the third term is the variance:
the expected squared deviation of x′0βˆ around its mean. We generally try to minimize
the mean squared error or expected prediction error for a model. Interpretability of a
model, on the other hand, is more qualitative in nature, and involves discerning which
variables play an important role in predicting the response.
Ordinary least squares (OLS) minimizes the residual sum of squares
n∑
i=1
(
yi −
p∑
j=1
βjxij
)2
.
It is intuitively appealing, but OLS fitting does not always provide a satisfactory model
in terms of prediction accuracy and interpretability. It produces best linear unbiased
estimators, but the variance of the predicted values is often high. The interpretability
of the model is also seriously hampered since OLS retains all the predictors. With too
many variables in the model, it is difficult to understand which variables are really
important in predicting the response. Moreover, in the high-dimensional setting, it is
not possible get an OLS solution, there being no unique solution to the system of linear
equations involving the coefficients.
Traditional approaches to model selection, such as best subset regression or stepwise
regression, retain a subset of the candidate predictors, eliminate the rest, and use
OLS to estimate the coefficients corresponding to the ones retained. Subset selection
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generally achieves better prediction accuracy than the full model by selecting a only
a subset of the candidate predictors. The selection of the subset of variables is based
on either best subset regression or forward/backward stepwise selection. Best subset
regression is generally considered impractical for p > 30. Backward selection can only
be used when N > p, while forward selection can always be used. Hybrid strategies
using both forward and backward moves in each step can also be used. The best subset
size or the best model among the sequence of models produced by each of the above
procedures is the tuning parameter and typically the model that minimizes an estimate
of the test error is chosen. Subset selection, though conceptually simple and produces
easily interpretable models, has serious drawbacks. It is a discrete process, i.e., either
makes a coefficient zero or inflates it. This inherent discreteness makes subset selection
extremely variable. It is not stable with respect to small perturbations in the data.
Ridge regression (Hoerl and Kennard 2000) ( Hoerl and Kennard, 1970), on the
other hand, retains all the predictors in the model and modifies how the coefficients
are estimated. The ridge estimate βˆ is defined by
βˆ = arg min

n∑
i=1
(
yi −
∑
j
βjxij
)2 subject to ∑
j
β2j ≤ t ,
where t is the tuning parameter. The above optimization problem can be equivalently
expressed as,
βˆ = arg min

n∑
i=1
(
yi −
∑
j
βjxij
)2
+ λ
∑
j
β2j
 .
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There is one-to-one correspondence between t and λ. The tuning parameter is chosen
to minimize an estimate of the expected prediction error. Ridge regression achieves
better performance than OLS through a bias-variance trade-off. It is a continuous
process and the ridge estimates are stable, i.e., if we delete a single data point, the new
ridge estimates, for the same tuning parameter will be close to the old. However, ridge
estimates retain all the predictors in the model resulting in less interpretability. Ridge
regression can be used in the high-dimensional setting.
Methods which select subsets and shrink estimates simultaneously would be more
welcome as they would retain good features of both subset selection and ridge regression.
Breiman (1995) proposed the nonnegative garrote for better subset regression. His
procedure minimizes
n∑
i=1
(
yi −
∑
j
cjβˆ
0
jxij
)2
subject to cj >= 0,
∑
j
cj ≤ t ,
where βˆ0j are the OLS estimates and βˆj(t) = cj(t)βˆ
0
j are the new estimates. The
nonnegative garrote starts with the OLS estimates and then as we tighten the garrote,
some of the coefficients are set to zero and the remaining ones are shrunk. Breiman
showed via simulations that nonnegative garrote outperforms subset selection and is
comparable to ridge regression unless the model has a large number of small effects.
In terms of stability, nonnegative garrote is intermediate between subset selection and
ridge regression. But it depends heavily on the OLS estimates, the nonnegative garrote
estimates are expected to suffer in situations where the OLS estimates perform poorly,
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and cannot be used when there are more predictors than samples.
Motivated by the idea of nonnegative garrote, Tibshirani (1996) proposed a new
technique called LASSO: least absolute shrinkage and selection operator. The LASSO
estimate βˆ is defined by
βˆ = arg min

n∑
i=1
(
yi −
∑
j
βjxij
)2 subject to ∑
j
|βj| ≤ t .
LASSO can produce sparse solution. When there are a large number of candidate
predictors parsimony is an important issue. LASSO can be implemented in the high-
dimensional setting but it cannot select more variables than number of observations.
Frank and Friedman (1993) introduced bridge regression and Fu (1998) developed a
general approach to solve for bridge estimators. Bridge regression minimizes

n∑
i=1
(
yi −
∑
j
βjxij
)2 subject to ∑
j
|βj|q ≤ t .
It includes subset selection (q = 0), LASSO (q = 1), and ridge regression (q = 2) as
special cases. Huang et al. (2008) studied the asymptotic properties of bridge estimators
for an increasing number of predictors.
Fan and Li (2001) proposed a non-convex penalty function, the smoothly clipped
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absolute deviation (SCAD) penalty. The SCAD penalty function is defined as follows:
pλ(|βj|) =

λ|βj|, |βj| ≤ λ
− |βj |2−2aλ|βj |+λ2
2(a−1) , λ < |βj| ≤ aλ
(a+1)λ2
2
, |βj| > aλ
,
where a and λ are the tuning parameters and are chosen such that they minimize an
estimate of the expected prediction error. They have shown via simulations that the
choice a ≈ 3.7 works quite well for various variable selection problems. In the context of
SCAD penalty they argued that a “good” penalty function should be unbiased, sparse,
and continuous in data and showed that SCAD penalty possesses all three desirable
properties. Fan and Peng (2004) discussed asymptotic properties of the non-concave
penalized likelihood estimator when the number of covariates increase to infinity with
the sample size. Zou and Li (2008) suggested one-step sparse estimates based on local
linear approximation (LLA) for maximizing the penalized likelihood for concave penalty
functions.
All the methods described above can be viewed as applying different penalty func-
tions to the OLS criterion and can be regarded as penalized least squares procedures.
A form of the penalized least squares objective function is
(y −Xβ)′(y −Xβ) +
p∑
j=1
pλ(|βj|) . (5.2)
Minimizing (5.2) with respect to β gives penalized least squares estimator of β. The
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penalty functions pλ(|βj|) do not have to be the same for all j and are allowed to
depend on λ. The L2 penalty function pλ(|βj|) = λ|βj|2 corresponds to ridge regression,
while the L1 penalty function pλ(|βj|) = λ|βj| to LASSO. The L0 or entropy penalty,
pλ(|βj|) = λI(|βj| 6= 0), corresponds to variable subset selection. Nonnegative garrote,
also, can be expressed as penalized least squares with additional sign constraints,
βˆ = arg min

n∑
i=1
(
yi −
∑
j
βjxij
)2
+ λ
∑
j
|βj|
|βˆ0j |
 subject to βjβˆ0j ≥ 0 ∀j.
When the columns of X are orthonormal, the penalized least squares problem boils
down to minimizing
(βˆ0j − βj)2 + pλ(|βj|)
for each j separately. This simplification allows us to study the estimator as a function
of the data. In this special case, the L1 penalty function yields
βˆj = sign(βˆ
0
j )(|βˆ0j | − γ)+ ,
where γ depends on λ. This is called ‘soft threshold’ estimator by Donoho and JOHN-
STONE (1994) and is typically used in the wavelet analysis. The ridge solution for
orthonormal X is,
βˆj =
1
1 + γ
βˆ0j .
100
The nonnegative garrote estimate is
βˆj =
(
1− γ
βˆ0j
2
)+
βˆ0j .
The hard thresholding penalty function pλ(|βj|) = λ2− (|βj| − λ)2I(|βj| < λ) results in
the hard thresholding rule
βˆj = βˆ
0
j I(|βˆ0j | > γ) .
The hard thresholding rule is also derivable from the entropy penalty function. For
orthonormal X the resulting SCAD estimator is given by
βˆj =

sign(βˆ0j )(|βˆ0j | − γ)+, |βj| ≤ 2λ{
(a− 1)βˆ0j − sgn(βˆ0j )aλ
}
/(a− 2), 2λ < |βj| ≤ aλ
βˆ0j , |βj| > aλ
.
We have plotted these estimators as functions of the data in Figure (5.1). The hard
thresholding penalty, corresponding to plot (a), satisfies sparsity and unbiasedness, but
it is not continuous in data. Plot (b) shows that the ridge estimator is continuous, but
it is neither a thresholding rule nor is it unbiased for large values of the parameter.
The LASSO penalty corresponding to plot (d) suggests that LASSO satisfies sparsity
and continuity but not unbiasedness. The SCAD rule, as we had mentioned before,
satisfies all three properties and so does the nonnegative garrote.
The penalized least squares estimators are biased but their variance is smaller than
the OLS estimator, thus with a little sacrifice of bias we can achieve better performance
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on the average in terms of mean squared error or prediction error. Some of these penalty
functions restrict the coefficients in such a way that a number of them are reduced
to zero, thus effectively performing variable selection. The idea of applying penalty
functions to the OLS criterion can be extended to penalized likelihood to encompass
likelihood-based models. A form of the penalized log-likelihood is
n∑
i=1
li −
p∑
j=1
pλ(|βj|) ,
where li is the log-likelihood for yi. In the linear regression setup the penalized least
squares and the penalized likelihood estimators are exactly the same for type 1 penalty
functions defined by Zou and Li (2008), such as the bridge penalties or the logarithm
penalty.
The penalized likelihood estimators can be interpreted from a Bayesian point of
view. The penalty functions can be thought of as log-prior densities for the parame-
ters. Thus LASSO can be viewed as Bayes posterior mode under independent Laplace
priors and ridge estimate can be interpreted as mode of the posterior distribution with
independent Gaussian priors for the parameters. Since the posterior distribution is
Gaussian, the ridge estimator is also the posterior mean. The SCAD penalty corre-
sponds to an improper prior. Thus LASSO, ridge, and SCAD are all Bayes estimates
but with different prior distributions for the regression coefficients (Hastie et al. 2001;
Tibshirani 1996).
Efron et al. (2004) proposed least angle regression, and its LASSO and forward
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stagewise variations (LARS). Their paper describes a new model selection algorithm,
simple modifications of which give LASSO and forward stagewise regression. It has
revolutionized the way LASSO is implemented, implementation being a natural con-
cern for very large number of predictors. Although LASSO is a very appealing variable
selection tool, it has a few drawbacks. In high-dimensional scenario, LASSO does not
perform satisfactorily, it cannot choose more variables than number of samples. Also, if
there is a group of correlated variables among which the pairwise correlations are very
high, then LASSO tends to choose any one variable from the group. In the usual re-
gression setup, if the correlation between the predictors is high, ridge regression usually
outperforms LASSO. In an attempt to retain good features of both ridge regression and
LASSO, Zou and Hastie (2005) presented a new regularization and variable selection
method, the elastic net, which is particularly useful when there are more variables than
observations. The na¨ıve elastic net criterion minimizes

n∑
i=1
(
yi −
∑
j
βjxij
)2+ λ1∑
j
|βj|+ λ2
∑
j
β2j . (5.3)
(5.3) is equivalent to the minimizing

n∑
i=1
(
yi −
∑
j
βjxij
)2 subject to (1−γ)∑
j
|βj|+γ
∑
j
β2j ≤ t , γ =
λ2
λ1 + λ2
∈ [0, 1] ,
where the elastic net penalty (1− γ)∑j |βj|+ γ∑j β2j is a convex combination of the
lasso and the ridge penalty. The na¨ıve elastic net is a two-step procedure: ridge-type
shrinkage followed by lasso-type thresholding, double shrinkage does not help much
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with variance while introducing extra bias. The elastic net estimator is a rescaled
na¨ıve elastic net estimator, that corrects for the double shrinkage and is defined as
βˆ(elastic net) = (1 + λ2)βˆ(na¨ıve elastic net) .
Elastic net exhibits the attractive property of “grouping effect”: highly correlated pre-
dictors have the same regression coefficients. LASSO does not possess this property
(Zou and Hastie 2005).
With high-dimensional data, there are two different objectives: ensuring high predic-
tion accuracy and identifying the set of predictors with nonzero regression coefficients.
Identifying the true “sparse pattern”, referred to as variable selection consistency, is
particularly important when the true underlying model is sparse. LASSO variable se-
lection is not necessarily consistent. Hence, LASSO is not an oracle procedure (Fan
and Li 2001; Zou 2006). We call a procedure, δ, an oracle procedure (Fan and Li 2001;
Zou 2006) if βˆ(δ) has the following properties asymptotically:
• identifies the right subset model,
{
j, βˆj 6= 0
}
= {j, βj 6= 0}
• has the optimal estimation rate, √n
(
βˆ(δ)− β
)
→D N(0,Σ∗), where Σ∗ is the
covariance matrix knowing the true subset model.
Zou (2006) proposed a variation of lasso, adaptive LASSO, which minimizes
βˆ = arg min

n∑
i=1
(
yi −
∑
j
βjxij
)2
+ λ
∑
j
wˆj|βj|
 ,
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where wˆ = 1/|βˆ|γ, γ > 0, and βˆ is a root-n consistent estimator of β. Adaptive LASSO
is fast, effective, and enjoys the oracle property. By incorporating data-dependent
weights adaptive LASSO manages to reduce the bias of LASSO. The weights make the
resulting estimator nearly unbiased when the true unknown parameter is large. Huang
et al. (2007) studied the asymptotic properties of adaptive LASSO for sparse high-
dimensional regression models when number of covariates increase with the sample
size. When the number of predictors exceeds the sample size they show that under
the partial orthogonality condition adaptive LASSO is an oracle procedure if marginal
regression is used to obtain the initial estimator.
Yuan and Lin (2006) studied a slightly different problem of selecting grouped vari-
ables (factors) for achieving better prediction accuracy in regression problems where
interest lies in finding important explanatory factors for the response variable. They
extended LASSO, LARS, and nonnegative garrote to group LASSO, group LARS, and
group nonnegative garrote for factor selection. Wang et al. (2007) developed group
SCAD regression in the same spirit. Candes and Tao (2007) proposed the Dantzig se-
lector. Wasserman et al. (2007) advocated a three-stage procedure: in the first stage a
set of candidate models: LASSO, marginal regression, and forward stepwise regression,
are fitted to the data, in the second stage one of them is selected by cross-validation, and
in the third stage hypothesis testing is used to eliminate some of the variables. The first
two stages are referred to as “screening” and the third one is the “cleaning” stage. Rad-
chenko and James (2008) described a modification to LASSO to prevent overshrinkage
of LASSO by using two tuning parameters, one for selecting variables and the other to
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control the amount of shrinkage. They call it VISA: Variable Inclusion and Shrinkage
Algorithms. Fan and Lv (2006) introduced the concept of sure independence screening
in ultrahigh-dimensional problems and described a sure screening method based on a
correlation learning, called the Sure Independence Screening (SIS). James et al. (2009)
explored the relationship between LASSO and Dantzig selector and described a new
algorithm, DASSO, which uses a LARS-type algorithm to compute the entire solution
path for the Dantzig selector. There are many other methods in the model selection
literature that have been proposed for simultaneous variable selection and coefficient
shrinkage.
We present a method that involves the two principal components of model selec-
tion: variable selection and estimation of the coefficients corresponding to the selected
variables. To select a variable, we test whether the regression coefficient corresponding
to that variable is zero or not, based on the observed test coefficient. Then we estimate
the regression coefficient based on a conditional likelihood that takes into account the
result of the testing of hypothesis. We incorporate the information of whether the vari-
able was found to be significant or not while constructing the conditional likelihood for
estimation. This idea is an application of the conditional likelihood approach (Ghosh
et al. 2008)) to overcoming the “winner’s curse” (Lohmueller et al. 2003; Zo¨llner and
Pritchard 2007), or “significance bias” (Ghosh et al. 2008)), in genome-wide associa-
tion studies. The conditional likelihood suggests a non-convex penalty function that
can be used in the penalized likelihood framework for coefficient shrinkage. Thus, our
proposed penalty function has a natural motivation based on the selection procedure
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involving the test coefficient. We call the resulting method Test Coefficient Shrinkage
or TCS.
With focus on ensuring high prediction accuracy, we describe a penalization tech-
nique based on the TCS penalty in the linear regression framework. We extend our
method to high-dimensional regression problems. We illustrate the performance of our
approach via extensive simulations. We use a real data example that has been widely
used in the model selection literature to compare the performances of different meth-
ods. We judge the performance of TCS and other popular methods such as LASSO,
ridge, and SCAD using simulations for both the usual scenario where we have more
observations than covariates and the high-dimensional setup with more predictors than
observations. The simulations cover a wide range of models.
5.2 Methods
Consider the linear regression model (5.1). Our goal is to find the best linear fit to the
data in terms of prediction error. With this objective in mind, we propose a shrinkage
method based on penalized likelihood. In the linear regression setup the penalized
log-likelihood assumes the form
lpenalized(β, σ
2) = −n log σ − 1
2σ2
(y −Xβ)′(y −Xβ)−
∑
j
pλ(|βj|) . (5.4)
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We suggest a novel penalty function, TCS penalty,
pλ(|βj|) = log [Φ(−λ− µj) + Φ(−λ+ µj)] ,
where we define µj =
βj
SE(βˆ0j )
,. The motivation for this penalty function stems from
accounting for the testing of a regression coefficient to select it. Let us consider the
situation where we have only one predictor x,
yi = βxi + i, i = 1, . . . , n ,
and we assume that the error variance σ2 is known. Our goal is to build a model
for y. We first test whether x has any predictive ability, that is, we test the null
hypothesis H0 : β = 0 against the alternative H1 : β 6= 0 on the basis of the test
statistic Z = βˆ
0
SE(βˆ0)
= βˆ
0
σ
. We reject H0 if the observed Z is greater in magnitude than
some prespecified quantity λ. If H0 : β = 0 is accepted, then we predict y using y¯. If
we reject the null, we need an estimate for β to be able to predict y. We construct a
conditional likelihood for β which takes into account the fact that the null has been
rejected. We note that Z ∼ N(µ, 1), where µ = β
σ
. The conditional likelihood for µ is
Lc(µ) =
pµ(z)
P (|Z| > λ)
=
φ(z − µ)
Φ(−λ− µ) + Φ(−λ+ µ) . (5.5)
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We maximize Lc(µ) with respect to µ to derive µ˜, the conditional maximum likelihood
estimate of µ. µ˜ may be regarded as a penalized likelihood estimator with the TCS
penalty log [Φ(−λ− µ) + Φ(−λ+ µ)] since
µ˜ = arg maxµ Lc(µ)
= arg maxµ {log φ(z − µ)− log [Φ(−λ− µ) + Φ(−λ+ µ)]} .
µ˜ can be easily converted to an estimate for β using the one-to one correspondence
β˜ = µ˜σ. We can alternatively think of β˜ as
β˜ =

0 , accept H0
µ˜σ , reject H0
. (5.6)
Thus β˜ is a thresholding rule shrinking the estimate βˆ0 to zero if we accept the null
hypothesis and shrinking it to some non-zero value if the null is rejected, the amount
of shrinkage being determined by λ. Larger the value of λ, the greater is the shrinkage.
The rule β˜ is not continuous in the observed data βˆ0. If we believe continuity of a
penalty function to be a desirable property as advocated by Fan and Li (2001), we can
make the rule β˜ continuous in βˆ0 by defining β˜ as
β˜ = µ˜σ . (5.7)
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Thus, if we accept the null hypothesis, instead of shrinking the estimate βˆ0 all the
way to zero, the new rule shrinks it to a value very close to zero. With this new
definition, β˜ loses its natural motivation as a test coefficient shrinkage and is no longer
a thresholding rule, thus not engaging in variable selection anymore. We can consider
β˜ as a shrinkage estimator of β. We plot the TCS estimator β˜ as a function of βˆ0 using
both the thresholded definition (5.6) and the non-thresholded (5.7) one.
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Figure 5.1: Plots of shrinkage estimators as function of data for (a) hard thresholding
rule, (b) ridge, (c) nonnegative garrote, (d) LASSO, (e) SCAD, (f) thresholded TCS,
and (g) non-thresholded TCS where X is orthonormal, λ = 2, and a=3.7
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We use the TCS penalty function log [Φ(−λ− µ) + Φ(−λ+ µ)] in the penalized
likelihood framework to obtain shrinkage estimates of regression coefficients. There is
a Bayesian interpretation to our proposed TCS penalty.
log φ(z − µ)− log [Φ(−λ− µ) + Φ(−λ+ µ)]
can be thought of as log posterior density for µ, where the prior for µ is p(µ) ∝
1
[Φ(−λ−µ)+Φ(−λ+µ)] . This results in considering µ˜ as Bayes posterior mode. Substituting
the TCS penalty in (5.4) we get
lpenalized(β, σ
2) = −n log σ − 1
2σ2
(y −Xβ)′(y −Xβ)
−
∑
j
log [Φ(−λ− µj) + Φ(−λ+ µj)] . (5.8)
To obtain penalized maximum likelihood estimate of β for a given λ, we maximize
(5.8) with respect to (β, σ2). We choose λ to minimize an estimate of the expected
prediction error.
5.2.1 High-dimensional setup
We would like to apply our method in the high-dimensional case. For p > n setup, the
direct application of the penalized likelihood with the TCS penalty is not feasible since
the penalty term involves standard error of OLS estimates, and OLS estimates are not
defined in the high-dimensional situation. But we can apply our penalty if we consider
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a subgroup of variables less than the number of observations where we can find OLS
estimates. In particular, if we regress on a single predictor then we can obtain shrinkage
estimate for the regression coefficient by applying our penalty. Any standard software
would give us βˆ0 and SˆE(βˆ0) from a univariate regression. We define Z = βˆ
0
SˆE(βˆ0)
.
Using the well-known asymptotic result βˆ
0−β
SˆE(βˆ0)
d→ N(0, 1), we have the approximate
asymptotic result Z
.∼ N(µ, 1), where µ = β
SˆE(βˆ0)
is not exactly a parameter. We can
implement either the thresholded or the non-thresholded version of TCS penalty. The
thresholded estimate would be
β˜ =

0 , |z| ≤ λ
µ˜SˆE(βˆ0) , |z| > λ
,
where µ˜ = arg maxµ
φ(z−µ)
Φ(−λ−µ)+Φ(−λ+µ) . The non-thresholded estimate would be β˜ =
µ˜SˆE(βˆ0).
We develop an iterative procedure where we apply this univariate regression idea
with residuals as the response variable. This idea is similar to the coordinate-wise
descent algorithms (Friedman et al. 2007) for convex optimization problems. At each
step of the iterative procedure we start with an initial estimator, update it one regression
coefficient at a time, and then repeat this process with the updated estimate as the
initial value for the next iteration. Let β˜
(k−1)
be the initial estimator of β at the kth step
of the procedure. We use the subscript −j to signify that the jth column or component
is left out. For the jth predictor we regress y −X−jβ˜−j on xj, get β˜ by shrinking βˆ0,
and replace β˜
(k−1)
j by β˜. We then move on to the next predictor. After we are finished
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with all the predictors we have β˜
(k)
. We then start the (k + 1)th step with β˜
(k)
as the
initial estimator. Getting β˜ from βˆ0 is very fast and the computation of the residuals
is also quick because only one component gets updated each time which makes the
whole iterative procedure very efficient. For the first step we define β˜
(0)
as a vector of
β˜’s obtained by shrinking the marginal regression coefficients. For a particular step of
the iteration we have to loop through all the predictors, one predictor at a time, but
we need to decide on a order in which to loop through the variables. We enter the
predictors in decreasing order of magnitude of the initial estimator for that iteration.
We decided on this order so as to eliminate any random element in the process and
end up with the same estimate of β every time we run the procedure for a particular
dataset. Also, we need a stopping rule for the iterative procedure. Tseng (1988) has
established that coordinate-wise algorithms for convex optimization problems converge
to their optimal solution under separability of the penalty function. For TCS penalty,
the iterative procedure does not enjoy such convergence properties since the penalty
function is not convex. So we continue the iteration for 50 steps and then choose the β˜
which gives the minimum training error in the last 10 steps. This strategy is based on
the empirical observation that the training and the test errors have similar paths over
the iteration steps which led us to believe that training error can serve as a stopping
rule criterion.
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5.2.2 Numerical examples
We apply our method to a data on prostrate cancer widely used in the variable selection
literature. The data comes from a study conducted by Stamey et al. (1989). The
dependent variable is lpsa: level of prostate specific antigen in blood serum. The
relevant covariates are a number of clinical measures in men about to receive a radical
prostatectomy: lcavol (log cancer volume), lweight (log prostate weight), age, lbph (log
of the amount of benign prostatic hyperplasia), svi (seminal vesicle invasion), lcp (log
of capsular penetration), gleason (Gleason score), and pgg45 (percent of Gleason scores
4 or 5). We first standardize the predictors to have 0 mean and unit variance. We
randomly split the data into a training set of size 67 and a test set of size 30. We
applied OLS, LASSO, ridge, SCAD, and TCS to compare how each method performs
in finding the best linear fit to the data. Every method, other than OLS, involves a
tuning parameter which is chosen to minimize an estimate of the prediction error based
on 10-fold cross-validation. We follow a “one-standard error” rule, in which the least
complex model is chosen whose estimated prediction error is one standard deviation
above the minimum estimated prediction error. This conservative approach follows
from the thought that prediction error is estimated with some error. The final chosen
model is then applied to the test set to assess its prediction error.
We use a simulation study to compare TCS with OLS, ridge, LASSO, and SCAD
in the usual n > p situation. We simulated 100 datasets consisting of n observations
from the model
ynx1 = Xnxpβpx1 + nx1 ,  ∼ Nn(0, σ2In) ,
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where β = (3, 1.5, 0, 0, 2, 0, 0, 0)′. The columns of X and  are standard normal. The
correlation between xi and xj is ρ
|i−j| with ρ = 0.5. This numerical example is used
in several publicationsFan and Li (2001); Tibshirani (1996); Zou and Hastie (2005) to
discuss relative merits of different variable selection and shrinkage procedures. First
we choose σ = 3 and n = 40. Then we reduce σ to 1 and finally increase the sample
size to 60. We use 5-fold cross-validation to choose the complexity parameter. The
mean squared error of each procedure is compared relative to that of OLS. We use the
median of the relative mean squared errors over 100 datasets (MRMSE) to compare
performance of different methods. We have also compared the performance of an oracle
estimator to OLS.
To judge the performance our proposed method in the p > n situation, we simulate
data from the same linear model but with fewer observations than predictors. We set
n = 100, p = 1000, and σ = 1. The non-zero β’s constitute a random sample from
normal distribution with mean zero and variance σ2β. We examine the performance
of TCS, both the thresholded and the non-thresholded versions, and compare it with
LASSO and ridge regression over a range of simulation setups, generated by varying
the number of non-zero predictors p1 from 5 to 1000 and σβ from 0.1 to 2. LASSO
is known to perform well in situations where we have a few big predictors and ridge
usually performs better than LASSO in cases where we have many small predictors.
Thus, in our simulation setup, we cover the two extreme situations of having very
few big predictors and many small ones. Through our numerical exercise we plan to
verify the empirical observations about LASSO and ridge regression and also hope to
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understand in which cases our method works better than either of the two or in which
cases it fails to perform well. For each simulation setup we compute the estimated test
error for all three methods over 100 replications and judge their relative performance
on the basis of the average test error. For each replication we have a training set of
size n to fit the model over a range of values of the tuning parameter, a validation set
of size n on the basis of which we decide on the value of the tuning parameter, and a
test set of size 10,000 to estimate the test error of the fitted model. We standardize
the covariates and center the response variable before analysis.
5.3 Results
Table 5.1 shows the results for the prostate cancer data for different variable selection
and shrinkage methods. We see that ridge regression reduces OLS test error only by
a small margin whereas LASSO offers remarkable improvement over OLS. Test error
for SCAD is slightly lower than that for LASSO. Our proposed penalty has the lowest
test error. If we compare the standard errors of the test error estimates for different
methods, TCS penalty has the smallest.
Table 5.2 shows the results for the simulations in the n > p setup. The median of the
relative mean squared errors over 100 datasets (MRMSE) are reported in Table 5.2.
When the noise level is high and sample size is small, i.e., σ = 3 and n = 40, LASSO
performs the best but deteriorates quickly as signal to noise ratio increases, i.e., as
we decrease σ or increase n. When the noise level is reduced, the proposed shrinkage
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Table 5.1: Estimated coefficients and test error results for prostate data
Term OLS Ridge LASSO SCAD TCS
Intercept 2.480 2.469 2.479 2.484 2.478
lcavol 0.680 0.322 0.552 0.803 0.800
lweight 0.305 0.206 0.192 0.144 0.044
age -0.141 -0.004 0.000 -0.005 0.000
lbph 0.210 0.135 0.035 0.039 0.024
svi 0.305 0.190 0.115 0.001 0.019
lcp -0.288 0.061 0.002 -0.002 -0.004
gleason -0.021 0.048 0.000 0.000 0.005
pgg45 0.267 0.109 0.003 0.000 0.021
Test Error 0.586 0.548 0.486 0.482 0.461
Std. Error 0.184 0.179 0.154 0.135 0.133
Table 5.2: Results for simulated numerical example in n > p scenario
MRMSE(%)
Method n=40, σ = 3 n=40, σ = 1 n=60, σ = 1
Oracle 41.49 62.70 68.23
Ridge 89.59 100.00 100.00
LASSO 81.18 86.34 85.72
SCAD 95.12 72.41 73.63
TCS 85.89 70.55 72.88
method has the lowest MRMSE and it performs as well as the oracle procedure as signal
to noise ratio increases. Ridge regression performs extremely poorly. Performance of
SCAD is comparable to our penalty function for high or moderate signal to noise ratio
but for high noise level and small sample size our shrinkage method clearly outperforms
SCAD. Table 5.2 suggests that the proposed penalty performs remarkably well and is
indeed a worthy competitor.
Table 5.3 shows the results for TCS, LASSO, and ridge for the simulation in the
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p > n situation. The different columns of the table are for the number of non-zero
predictors and the rows signify different values of σβ. For each cell corresponding to
a particular number of non-zero predictors and a value of σβ we have recorded the
average test error over 100 datasets for TCS, thresholded and non-thresholded versions
of it, LASSO, and ridge in increasing order of magnitude. We have color-coded the
different methods so that it is easy to visualize which method does best in a particular
situation. The non-thresholded TCS is coded in cyan blue and the thresholded TCS in
navy blue. LASSO is in red, ridge in green.
If we are interested in a particular method we can trace the corresponding color
across the grid and its positions in various cells, in terms of first, second, third, or
fourth, gives us its overall performance. For example, if we compare the red (LASSO)
and the green (ridge) paths we observe that in situations where we have fewer non-zero
predictors than samples LASSO does better than ridge, while ridge does better than
LASSO when the number of non-zero predictors is greater than the sample size. In
the latter situation, LASSO is at a disadvantage since it cannot choose more predictors
than number of observations. In the case where there are equal number of non-zero
predictors and observations, LASSO and ridge are very close, but LASSO does better
when the non-zero coefficients are big whereas ridge outperforms LASSO when the
non-zero coefficients are small in magnitude.
The first two columns of the table shows that thresholded TCS (navy blue) has
the smallest test error among all the methods when β is truly sparse. But it performs
poorly in situations where we have more non-zero predictors than samples. If we
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compare it with LASSO we find that thresholded TCS has smaller average test error in
very sparse situations but LASSO takes over as we increase the number of non-zero β’s
till we saturate β with all non-zero components. The difference in the performances of
thresholded TCS and LASSO narrows down as we decrease σβ.
The non-thresholded TCS never is the best choice other than for the situations
where σβ = 0.1 and number of non-zero variables is 50 and 100. But from this table
we can definitely conclude that it is the best choice in terms of overall performance. It
is almost always the second choice. In sparse situations it is practically the same as
thresholded TCS and significantly better than either LASSO or ridge. When we have
50 non-zero predictors, LASSO usually has the smallest test error, but non-thresholded
TCS is only second to it and as the β’s become smaller in size it approaches LASSO
and finally takes over for σβ = 0.1. In the situation where there are more non-zero
predictors than number of observations and ridge outperforms any other method, non-
thresholded TCS is close behind and performs remarkably better than LASSO. It is only
in the case where we have the same number of non-zero β’s as the number of samples
that non-thresholded TCS is unable to beat any of the two most popular methods, but
the difference between them decreases as we make the β’s smaller in magnitude and
finally non-thresholded TCS outperforms both LASSO and ridge.
renewcommand21.5
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Table 5.3: Simulation results for p > n
Number of non-zero predictors
σβ 5 10 50 100 500 1000
2
1.11 1.19 117.50 335.24 1699.79 3379.85
1.12 1.22 136.87 335.88 1843.06 3628.62
1.50 2.24 147.90 352.74 1969.42 4019.68
17.16 32.69 168.85 383.04 2014.58 4032.96
1 1.17 1.37 31.23 84.32 425.84 845.80
1.19 1.41 36.39 84.85 460.77 906.27
1.44 2.02 39.64 88.17 494.16 1004.66
5.14 9.03 43.06 96.15 511.40 1006.20
0.5 1.21 1.50 9.24 22.09 107.34 212.31
1.22 1.52 10.53 22.14 115.30 227.68
1.33 1.70 11.12 22.85 123.88 252.74
2.12 3.09 11.62 24.82 127.01 255.05
0.1 1.05 1.09 1.47 1.93 5.39 9.59
1.05 1.10 1.49 1.96 5.60 10.08
1.06 1.10 1.50 1.98 6.00 11.06
1.15 1.19 1.53 1.99 6.04 11.12
5.4 Discussion
We have presented a model selection approach that can be used in the high-dimensional
setting. Our approach can either behave like ridge regression and perform only coeffi-
cient shrinkage or it can perform variable selection and coefficient shrinkage simultane-
ously, depending on the problem that we are interested in. The method is based on the
novel penalty that we propose: the TCS penalty. The motivation for this penalty comes
from the testing of hypothesis of regression coefficients for selecting the corresponding
predictors in the model. We have used this penalty in a penalized likelihood framework
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in the n > p situation. In the high-dimensional setup we have used it individually on
each predictor and developed an iterative procedure. We have shown via numerical
examples that our proposed method performs remarkably well in the n > p situation.
In the p > n scenario, TCS has lower prediction error than the popular competing ap-
proaches, such as LASSO or ridge, when the true coefficient vector is extremely sparse,
a situation where LASSO is known to dominate. When we have a large number of
non-zero predictors, TCS performs significantly better than LASSO and is very close
to ridge regression in terms of prediction error.
In the high-dimensional setting, we have judged the performance of the estimators
in terms of prediction error. But the number of β-coefficients wrongly predicted as non-
zero, better known as false-positives, or the number of β-coefficients wrongly predicted
as zero, known as false-negatives, can serve as criteria for judging the performance of
these methods. Obviously, ridge and the non-thresholded version of TCS select all the
candidate predictors and these measures will not mean much in their cases. But they
might be informative for comparing the performance of LASSO with the thresholded
TCS.
In the usual n > p setting we have used the TCS penalty in the penalized likelihood
framework and implemented coefficient shrinkage, but the penalty is not a threshold-
ing one and as a result does not participate in variable selection. We can implement
a thresholded version of this by investigating each predictor individually as we did in
the high-dimensional case. But we would have to deviate from the penalized likelihood
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framework where we optimize a single objective function over all the coefficients simul-
taneously. For future work, we plan to modify the TCS penalty to be a thresholding
rule.
In the high-dimensional case we describe an iterative procedure that examines each
predictor separately. So, the method for the high-dimensional model is not an automatic
extension of the method in the n > p situation. For future work in this area it would be
important to build an unified algorithm that can applied to both the situations. Also, it
would be help us understand the method better if we are able to compare it with other
high-dimensional model selection techniques in the regression setup. In most cases, it
is difficult to so in the absence of published code. We plan to develop a code that we
could distribute for everybody to use, That would also help us understand how our
method performs in various situations and how does it compare with other techniques.
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Appendix A
E(Z
∣∣|Z| > c) = K−1 [∫ −c
−∞
zφ(z − µ)dz +
∫ ∞
c
zφ(z − µ)dz
]
,
where K = Φ(−c+ µ) + Φ(−c− µ)
= µ+K−1
[∫ −c−µ
−∞
xφ(x)dx+
∫ ∞
c−µ
xφ(x)dx
]
, x = z − µ
= µ+K−1
[
(2pi)−1
∫ 1
2
(c+µ)2
∞
e−ydy + (2pi)−1
∫ ∞
1
2
(c−µ)2
e−ydy
]
,
y =
1
2
x2
= µ+K−1
[
(2pi)−1e−
1
2
(c−µ)2 − (2pi)−1e− 12 (c+µ)2
]
= µ+
φ(c− µ)− φ(c+ µ)
K
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Appendix B
B1. Eµ (Z| |Z1| > c) = µ +
 1
ρ
 φ(c−µ1)−φ(c+µ1)Φ(−c−µ1)+Φ(−c+µ1)
Eµ (Z| |Z1| > c) =
 Eµ (Z1||Z1| > c)
Eµ (Z−1| |Z1| > c)
 .
Now,
Eµ (Z1||Z1| > c)
=
∫
z−1
∫
|z1|>c
z1Lc(µ)dz1dz−1
=
∫
|z1|>c
z1
φ(z1 − µ1)
Φ(−c− µ1) + Φ(−c+ µ1) X∫
z−1
Np−1
(
z−1;µ−1 + ρ(z1 − µ1), R22 − ρρ′
)
dz−1dz1
=
∫
|z1|>c
z1
φ(z1 − µ1)
Φ(−c− µ1) + Φ(−c+ µ1)dz1
= µ1 +
φ(c− µ1)− φ(c+ µ1)
Φ(−c− µ1) + Φ(−c+ µ1)(2.2) ,
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and
Eµ (Z−1| |Z1| > c)
=
∫
z−1
∫
|z1|>c
z−1Lc(µ)dz1dz−1
=
∫
|z1|>c
φ(z1 − µ1)
Φ(−c− µ1) + Φ(−c+ µ1) X∫
z−1
z−1Np−1
(
z−1;µ−1 + ρ(z1 − µ1), R22 − ρρ′
)
dz−1dz1
= µ−1 + ρ
∫
|z1|>c
(z1 − µ1) φ(z1 − µ1)
Φ(−c− µ1) + Φ(−c+ µ1)dz1
= µ−1 + ρ
φ(c− µ1)− φ(c+ µ1)
Φ(−c− µ1) + Φ(−c+ µ1) .
Hence
Eµ (Z| |Z1| > c) = µ+
 1
ρ
 φ(c− µ1)− φ(c+ µ1)Φ(−c− µ1) + Φ(−c+ µ1) .
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B2. Proof of

µ˜
(2)
1 =
∫
µ1Lc(µ1)dµ1∫
Lc(µ1)dµ1
µ˜
(2)
−1 = z−1 − ρ(z1 − µ˜(2)1 )
:
µ˜
(2)
1 =
∫
µ1Lc(µ)dµ∫
Lc(µ)dµ
=
∫
µ1
µ1
φ(z1−µ1)
Φ(−c−µ1)+Φ(−c+µ1)
∫
µ−1
Np−1
(
z−1;µ−1 + ρ(z1 − µ1), R22 − ρρ′
)
dµ−1dµ1∫
µ1
φ(z1−µ1)
Φ(−c−µ1)+Φ(−c+µ1)
∫
µ−1
Np−1
(
z−1;µ−1 + ρ(z1 − µ1), R22 − ρρ′
)
dµ−1dµ1
=
∫
µ1
µ1Lc(µ1)
∫
µ−1
Np−1
(
µ−1; z−1 − ρ(z1 − µ1), R22 − ρρ′
)
dµ−1dµ1∫
µ1
Lc(µ1)
∫
µ−1
Np−1
(
µ−1; z−1 − ρ(z1 − µ1), R22 − ρρ′
)
dµ−1dµ1
=
∫
µ1
µ1Lc(µ1)dµ1∫
µ1
Lc(µ1)dµ1
,
and
µ˜
(2)
−1 =
∫
µ−1Lc(µ)dµ∫
Lc(µ)dµ
=
∫
µ1
Lc(µ1)
∫
µ−1
µ−1Np−1
(
z−1;µ−1 + ρ(z1 − µ1), R22 − ρρ′
)
dµ−1dµ1∫
µ1
Lc(µ1)dµ1
=
∫
µ1
Lc(µ1)
∫
µ−1
µ−1Np−1
(
µ−1; z−1 − ρ(z1 − µ1), R22 − ρρ′
)
dµ−1dµ1∫
µ1
Lc(µ1)dµ1
= z−1 − ρ(z1 − µ˜(2)1 ) .
127
B3. Formulae for estimates of covariances between
estimates of effect sizes for disease phenotype and
binary secondary phenotype for prospective and ret-
rospective study designs:
For data collected prospectively, we fit separate logistic regressions for D and Y ,
logit P (D = 1 | g) = α1 + β1g
logit P (Y = 1 | g) = α2 + β2g .
We need ˆcov(βˆ1, βˆ2) to perform the bias correction. We begin with some basic results.
Let l(θ) be any function of θ and l˙(θˆ) = ∂
∂θ
l(θ) |θ=θˆ = 0. Using Taylor expansion of l˙(θˆ)
about the true parameter value θ,
l˙(θ) + (θˆ − θ)l¨(θ∗) = 0 , where |θ − θ∗| < |θ − θˆ| .
Hence,
(θˆ − θ) = −
{
l¨(θ∗)
}−1
l˙(θ) ,
or approximately,
(θˆ − θ) = −
{
l¨(θ)
}−1
l˙(θ) .
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If l(θ) =
∑
log f(datai|θ) then (θˆ − θ) is asymptotically equivalent to V ar(θˆ)l˙(θ),
where V ar(θˆ) = I(θ)−1, I(θ) being the Fisher information matrix. Applying this for
θˆ1 = (αˆ1, βˆ1)
′ and θˆ2 = (αˆ2, βˆ2)′ we get
cov((θˆ1 − θ1), (θˆ2 − θ2)) = V ar(θˆ1)cov(l˙1(θ1), l˙2(θ2))V ar(θˆ2) ,
l˙1(θ1) =

∑{
di − exp(α1+β1gi)1+exp(α1+β1gi)
}
∑{
digi − gi exp(α1+β1gi)1+exp(α1+β1gi)
}
, and l˙2(θ2) =

∑{
yi − exp(α2+β2gi)1+exp(α2+β2gi)
}
∑{
yigi − gi exp(α2+β2gi)1+exp(α2+β2gi)
}
.
Therefore cov(l˙1(θ1), l˙2(θ2)) =

∑
cov(di, yi)
∑
gicov(di, yi)∑
gicov(di, yi)
∑
g2i cov(di, yi)
. We finally define
ˆcov(θˆ1, θˆ2) as,
ˆcov(θˆ1, θˆ2) = ˆV ar(θˆ1) ˆcov(l˙1(θ1), l˙2(θ2)) ˆV ar(θˆ2) ,
where ˆcov(l˙1(θ1), l˙2(θ2)) = ˆcov(d, y)
 n
∑
gi∑
gi
∑
g2i
. Thus ˆcov(βˆ1, βˆ2) would be the
(2,2)th element of the matrix ˆcov(θˆ1, θˆ2).
For case-control data we fit logistic regression for D, but for Y we have to con-
sider the retrospective likelihood. Since we perform the selection based on the ef-
fect size estimate obtained from the logistic regression of D on g, for the bias cor-
rection calculations we need an estimate of the covariance between βˆ1 obtained from
fitting logit P (D = 1 | g) = α1 + β1g and βˆ2 obtained from fitting the retrospec-
tive log-likelihood l =
∑
logP (Y = yi, G = gi|D = di). Let ψ = (α1, β1)′ and
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η = (β1, α2, β2, α3, β3, p(g))
′. From earlier theoretical discussion we can conclude that
cov(ψˆ, ηˆ) = V ar(ψˆ)cov(g˙(ψ), l˙(η))V ar(ηˆ) ,
where g(ψ) =
∑
logP (D = di|G = gi). Then
ˆcov(ψˆ, ηˆ) = ˆV ar(ψˆ) ˆcov(g˙(ψ), l˙(η)) ˆV ar(ηˆ) .
Since any standard statistical software would provide us with ˆV ar(ψˆ) and ˆV ar(ηˆ) we
only need to get ˆcov(g˙(ψ), l˙(η)). We use
ˆcov(g˙(ψ), l˙(η)) =
n∑
i=1
g˙i(ψˆ)l˙i(ηˆ)
′
. Finally, we get cov(βˆ1, βˆ2) as the (2,3)
th element of the matrix ˆcov(ψˆ, ηˆ).
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B4. Proof of cov(βˆ
(s)
G , βˆ
(b)
GE) = 0:
The log-likelihood for the full-model is,
l =
n∑
i=1
li
=
n∑
i=1
logP (D = di|G = gi, E = ei)
=
n∑
i=1
{
di(β
(b)
0 + β
(b)
G gi + β
(b)
E ei + β
(b)
GEgiei)
− ln(1 + exp(β(b)0 + β(b)G gi + β(b)E ei + β(b)GEgiei))
}
=
n∑
i=1
{diri (θ; gi, ei)− ln(1 + exp(ri (θ; gi, ei))}
=
n∑
i=1
{diri − ln(1 + exp(ri)} .
θˆ
(b)
is obtained by solving the likelihood equation l˙(θ) = ∂
∂θ
l = 0. From multivariate
Taylor expansion of the likelihood equation about the true parameter value θ it follows
that (
θˆ
(b) − θ(b)
)
= −l¨(θ)−1l˙(θ) , where
l˙(θ) =
n∑
i=1
l˙i(θ) , l˙i(θ) =

di − exp(ri)1+exp(ri)
gidi − gi exp(ri)1+exp(ri)
eidi − ei exp(ri)1+exp(ri)
gieidi − giei exp(ri)1+exp(ri)

, and
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−l¨(θ) = −
n∑
i=1
l¨i(θ) =
n∑
i=1

ci gici eici gieici
gici g
2
i ci gieici g
2
i eici
eici eigici e
2
i ci gie
2
i ci
eigici eig
2
i ci gie
2
i ci g
2
i e
2
i ci

, where ci =
exp(ri)
(1 + exp(ri))2
.
Hence,
(
βˆ
(b)
GE − β(b)GE
)
=
1∣∣∣−l¨(θ)∣∣∣
(
b41
n∑
i=1
(
di − exp(ri)
1 + exp(ri)
)
+b42
n∑
i=1
(
gidi − gi exp(ri)
1 + exp(ri)
)
+b43
n∑
i=1
(
eidi − ei exp(ri)
1 + exp(ri)
)
+b44
n∑
i=1
(
gieidi − giei exp(ri)
1 + exp(ri)
))
,
where b41, b42, b43, and b44 are the elements of the 4
th row of the conjugate matrix of
−l¨(θ). The analytical expressions for b41, b42, b43, and b44 are as follows:
b41 =
∑
gc
∑
e2c
∑
g2ec+
∑
g2c
∑
ec
∑
ge2c+ (
∑
gec)
3
−
∑
gc
∑
gec
∑
ge2c−
∑
g2c
∑
e2c
∑
gec−
∑
gec
∑
ec
∑
g2ec
b42 =
∑
c
∑
gec
∑
ge2c+
∑
gc
∑
e2c
∑
gec+ (
∑
ec)2
∑
g2ec
−
∑
c
∑
e2c
∑
g2ec−
∑
gc
∑
ec
∑
ge2c−
∑
ec(
∑
gec)
2
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b43 =
∑
c
∑
gec
∑
g2ec+ (
∑
gc)
2∑
ge2c+
∑
ec
∑
g2c
∑
gec
−
∑
c
∑
g2c
∑
ge2c−
∑
gc
∑
gec
2 −
∑
ec
∑
gc
∑
g2ec
b44 =
∑
c
∑
g2c
∑
e2c+ 2
∑
gc
∑
gec
∑
ec−
∑
c(
∑
gec)
2
−(
∑
gc)
2∑
e2c− (
∑
ec)
2∑
g2c
βˆ
(s)
G is the estimate of the disease risk effect obtained from fitting a logistic regression
of D on g. Hence βˆ
(s)
G is defined as
θˆ
(s)
=
 βˆ
(s)
0
βˆ
(s)
G
 = arg max n∑
i=1
{
di(β
(s)
0 + β
(s)
G gi)− ln(1 + exp(β(s)0 + β(s)G gi))
}
.
Hence,
(
θˆ
(s) − θ(s)
)
=
1
a1h1 − b21
 h1 −b1
−b1 a1


∑{
di − exp(β
(s)
0 +β
(s)
G gi)
1+exp(β
(s)
0 +β
(s)
G gi)
}
∑{
digi − gi exp(β
(s)
0 +β
(s)
G gi)
1+exp(β
(s)
0 +β
(s)
G gi)
}
 ,
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where a1 =
∑ exp(β(s)0 +β(s)G gi)
1+exp(β
(s)
0 +β
(s)
G gi)
, b1 =
∑ gi exp(β(s)0 +β(s)G gi)
1+exp(β
(s)
0 +β
(s)
G gi)
, and h1 =
∑ g2i exp(β(s)0 +β(s)G gi)
1+exp(β
(s)
0 +β
(s)
G gi)
.
This gives us
(
βˆ
(s)
G − β(s)G
)
=
a1
a1h1 − b21
∑{
digi − gi exp(β
(s)
0 + β
(s)
G gi)
1 + exp(β
(s)
0 + β
(s)
G gi)
}
− b1
a1h1 − b21
∑{
di − exp(β
(s)
0 + β
(s)
G gi)
1 + exp(β
(s)
0 + β
(s)
G gi)
}
.
⇒
cov(βˆ
(s)
G , βˆ
(b)
GE)
=
1∣∣∣−l¨(θ)∣∣∣ 1a1h1 − b21 cov
(∑
(b41 + b42gi + b43ei + b44giei) di,
∑
(a1gi − b1) di
)
∝ cov
(∑
w
(b)
i di,
∑
w
(s)
i di
)
,
where w
(b)
i = (b41 + b42gi + b43ei + b44giei) , w
(s)
i = (a1gi − b1)
=
∑
w
(b)
i w
(s)
i V ar(di)
=
∑
w
(b)
i w
(s)
i ci .
Now,
∑
w
(b)
i w
(s)
i ci = a1
(
b41
∑
gici + b42
∑
g2i ci + b43
∑
gieici + b44
∑
g2i eici
)
−b1
(
b41
∑
ci + b42
∑
gici + b43
∑
eici + b44
∑
gieici
)
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It can be shown that
b41
∑
gici + b42
∑
g2i ci + b43
∑
gieici + b44
∑
g2i eici = 0 ,
and
b41
∑
ci + b42
∑
gici + b43
∑
eici + b44
∑
gieici = 0 .
This leads to the result cov(βˆ
(s)
G , βˆ
(b)
GE) = 0.
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